| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
Merit Medical Systems, Inc.$73.44
+1.98 (+2.77%)
C 40Pipeline Score MedTech · Commercial
Market Cap
3.83 B
EPS
2.35
P/E Ratio
27.7 $
Value Trade
40.16 M
SEC Financials
Q1 2026Dilution Risk
Revenue
381.88 M
R&D Expenses
22.61 M
Operating CF
40.68 M
Total Assets
2.72 B
Total Liabilities
1.09 B
Equity
1.63 B
D/E Ratio
12,345
2.57 %
Week
-6.16 %
1 Month
-21.46 %
3 Month
-24.3 %
6 Month
4.1 %
5 Year
7,539.04 %
All Time
Cash Data
Cash Position
488.08 M
Monthly Burn
-
Runway
12,345 mo
Burn Trend
StableSEC Filing
Apr 30, 2026
Overview
Volume
769.00 K
52 Week Range
59.74 - 97.18
% held by Insiders
2.62 %
% held by Institutions
102.05 %
Enterprise Value
4.16 B
Total Shares
59.28 M
Short %
5.9 %
Float Shares
57.44 M
Company Description
locked
Upcoming Catalyst
Catalyst Timeline
Dated clinical, regulatory & corporate events for Merit Medical Systems, Inc.
742Total events
3Upcoming
173Tier-1 (high impact)
2007 – 2026Coverage
Upcoming catalysts 3
Event history 739
May 12, 2026
◆Oral PresentationPresentation
Merit Medical to participate in Bank of America Healthcare Conference fireside chat
Apr 1, 2026
▲AcquisitionCorporate
Merit acquires View Point Medical, Inc. (OneMark System) for $140M
oncologysource ↗
Mar 16, 2026
▲Product LaunchPost-Market
US commercial release of Resilience TTS Esophageal Stent
esophageal fistulas and strictures caused by malignant tumorssource ↗
Feb 24, 2026
Feb 17, 2026
▲AcquisitionDualCapCorporate
Merit sells DualCap product line assets to Health Line International for $28M
Jan 13, 2026
◆Oral PresentationPresentation
Merit Medical to present at 44th Annual J.P. Morgan Healthcare Conference
Jan 5, 2026
●Management ChangeCorporate
F. Ann Millner appointed Chair of the Board effective January 5, 2026
Jan 4, 2026
●Management ChangeCorporate
Fred P. Lampropoulos resigned as director and Chair on January 4, 2026
Dec 2025
◆Enrollment CompleteTrial
Final enrollment expected in WRAP Global registry
hemodialysis vascular access obstructionsource ↗
Drug Pipeline Intelligence
C40
Pipeline Score $227M
Pipeline ValueValuation Signal
10
Drugs Scored0.2x
rNPV / MCap Top 57%
Small Cap (rank 393 of 911)
Percentile RankMerit Medical Systems, Inc. carries a moderate pipeline score (40/100), with $349M risk-adjusted pipeline value, led by NUZ-001 in Amyotrophic Lateral Sclerosis (ALS) (Phase 2).
Showing 1 of 1 assets
| Drug | Indication | Phase | NCT ID | PTRS | rNPV | Status | Enrollment | Velocity | Design | Completion | ML Signal | Last Change |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NUZ-001 Small molecule | Amyotrophic Lateral Sclerosis (ALS) | Phase 2 | NCT07410806 | 21% | $43M | ENROLLING BY_INVITATION | 160 | - | - | Aug 1, 2028 | - | LOW May 24, 2026 |
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
WRAPSODY CIE | restoring vascular access in hemodialysis patients | — | 2025-11-05 | TLPP: 48.6% vs. 29.8%; p<0.0001; ACPP: 31.3% vs. 20.6%; p=0.003 Read More | Merit Medical Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula (AVF) Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial Read More | |
WRAPSODY CIE | restoring vascular access in hemodialysis patients | — | 2025-11-05 | TLPP: 48.6% vs. 29.8%; p<0.0001; ACPP: 31.3% vs. 20.6%; p=0.003 Read More | Merit Medical Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula (AVF) Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial Read More | |
WRAPSODY CIE | restoring vascular access in hemodialysis patients | — | 2025-11-05 | TLPP: 48.6% vs. 29.8%; p<0.0001; ACPP: 31.3% vs. 20.6%; p=0.003 Read More | Merit Medical Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula (AVF) Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial Read More |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in MMSI
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
MMSI Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
| 2026-10-16 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-10-16 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-10-16 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
MMSIMerit Medical Systems to Announce Second Quarter 2026 Results on July 30, 2026
Merit Medical Systems, Inc. will announce its financial results for Q2 2026 on July 30, 2026, after market close. An investor conference call is scheduled for the same day at 4:30 p.m. Eastern. The company continues to engage with investors and maintain transparency regarding its financial performance.
Read more →MMSISUMMARY OF MERIT MEDICAL SYSTEMS, INC. 2026 EQUITY INCENTIVE PLAN The following is a brief description of the principal features of the Merit Medical Systems, Inc. 2026 Equity Incentive Plan (the "2026 Equity Incentive P
Merit Medical Systems, Inc. has introduced the 2026 Equity Incentive Plan designed to incentivize its directors, employees, and consultants. The plan includes various award types, such as stock options and restricted stock units, with a total reserve of 2,700,000 shares. The Compensation Committee will oversee the selection and distribution of awards. This incentive plan will take effect until May 2036, aiming to align the interests of participants with those of shareholders.
Read more →MMSIMerit Medical Shareholders Elect Scott R. Ward to Board of Directors
Merit Medical Systems, Inc. has elected Scott R. Ward to its Board of Directors for a three-year term. His extensive experience in the healthcare and medical device industry, including leadership roles at Medtronic, is expected to contribute significantly to the company's strategic priorities. Ward's appointment is viewed positively by the Board and management, highlighting his potential impact on the company's growth.
Read more →MMSIMerit Medical to Participate in the Bank of America Healthcare Conference
Merit Medical Systems, Inc. will participate in the Bank of America 2026 Health Care Conference in Las Vegas from May 12-14, 2026. The management team is scheduled for a fireside chat on May 12th at 3:00 pm PT. A live audio webcast will be available, along with a replay for 90 days post-event.
Read more →MMSI▲ +5.2%on this news
Merit Medical Reports First Quarter 2026 Results and Updates Full-Year Guidance
Merit Medical Systems, Inc. reported a strong financial performance for Q1 2026, with a revenue increase of 7% to $381.9 million. Key highlights include a GAAP EPS of $0.68, a significant rise of 39%, and improved operating margins. The company also completed a strategic divestiture and an acquisition of View Point Medical, which is anticipated to enhance its oncology product portfolio. Guidance for full-year 2026 remains optimistic, with revenue projected between $1.612 billion and $1.634 billion.
Read more →MMSI▲ +5.2%on this news
PR/Media Inquiries: Sarah Comstock Merit Medical Investor Inquiries: Mike Piccinino, CFA, IRC ICR Healthcare +1-801-432-2864 +1-443-213-0509 sarah.comstock@merit.com mike.piccinino@icrhealthcare.com FOR IMMEDIA
Merit Medical Systems, Inc. announced its first quarter financial results for 2026, reporting revenue growth and solid earnings. The company achieved a 3.7% increase in organic revenue, alongside improvements in operating margins and free cash flow. Merit also provided updated guidance for the year, reflecting anticipated revenue contributions from its recent acquisition of View Point Medical. Overall, the results suggest a positive trajectory for Merit in achieving its financial goals for 2026.
Read more →MMSIMerit Medical Systems to Announce First Quarter 2026 Results on April 30, 2026
Merit Medical Systems, Inc. will announce its financial results for Q1 2026 on April 30, 2026. The results will be released after market close, followed by an investor conference call at 4:30 p.m. Eastern. The company is known for its proprietary medical devices across various medical fields.
Read more →MMSIMerit Medical Acquires View Point Medical, Inc., expanding the Merit Therapeutic Oncology Portfolio
Merit Medical Systems, Inc. has acquired View Point Medical, Inc. for approximately $140 million, enhancing its therapeutic oncology portfolio. The acquisition includes the OneMark Detection Imaging System, which aids in the localization of breast and soft tissue tumors. While projected revenue growth is promising, the acquisition will initially dilute Merit’s GAAP earnings per share.
Read more →MMSIMerit Medical Launches the Resilience Through-the-Scope Esophageal Stent
Merit Medical Systems, Inc. has announced the U.S. commercial release of its Resilience Through-the-Scope Esophageal Stent, designed for treating esophageal fistulas and strictures caused by malignant tumors. This stent features proprietary anti-migration flanges to enhance stability and is available in multiple sizes to meet various clinical needs. A single-handed deployment system allows for improved control during placement. The launch signifies a significant advancement in the TTS stent technology market, aiming to enhance patient care in endoscopic procedures.
Read more →MMSIMerit Medical Reports Fourth Quarter and Full Year 2025 Results and Issues Fiscal Year 2026 Guidance
Merit Medical Systems, Inc. announced strong financial results for Q4 and FY 2025, highlighting a 6.8% organic revenue growth and improved margins. The company generated over $215 million in free cash flow, marking a 16% year-over-year increase. For FY 2026, Merit provided optimistic guidance, emphasizing confidence in ongoing operational execution despite potential risks from trade policies and acquisitions.
Read more →MMSIMerit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025
Merit Medical Systems has announced the appointment of F. Ann Millner as Chair of the Board effectively from January 5, 2026, succeeding Fred P. Lampropoulos, who resigned as a part of a leadership transition. The announcement also included preliminary unaudited revenue results for the fourth quarter of 2025, indicating a notable increase compared to the previous year. The company plans to provide full financial results and guidance for fiscal year 2026 on February 24, 2026.
Read more →MMSIMerit Medical to Participate at the J.P. Morgan Healthcare Conference
Merit Medical Systems, Inc. will participate in the 44th Annual J.P. Morgan Healthcare Conference from January 12-15, 2026. CEO Martha G. Aronson and CFO Raul Parra will present on January 13th at 4:30 PM PT. Presentation materials and a live audio webcast will be available on the company's investor relations website.
Read more →MMSICelebrating a Year with HEART—Looking Back on Merit Medical Throughout 2025
As 2025 concludes, Merit Medical reflects on significant achievements including awards for workplace excellence, leadership changes, and recognitions for sustainability. The company celebrated its 35-year partnership with Nasdaq and welcomed its new CEO, Martha Aronson. Looking ahead, Merit is poised for continued growth and innovation in the healthcare sector.
Read more →MMSILeading by Example—Merit Asia Lives Core Values for a More Purpose-Driven Culture
Merit Medical's Asia facility emphasizes its core values, known as the Merit Way HEART values, to foster a purpose-driven culture. Senior Director Pamela Lee highlights initiatives that celebrate employee excellence and engagement, such as the HEART Award and a new orientation video. The company aims to integrate these values into hiring practices to build culturally-aligned teams from the start.
Read more →MMSIMerit Medical Provides Update on U.S. Reimbursement and Commercial Strategies for WRAPSODY Cell-Impermeable Endoprosthesis .
Merit Medical Systems has announced that the U.S. Centers for Medicare & Medicaid Services deferred its application for Transitional Pass-Through payment regarding the WRAPSODY Cell-Impermeable Endoprosthesis, with a potential effective date now set for January 2027. In response, Merit plans to adjust its commercial strategy aimed at increasing patient access while immediately starting to commercialize the device in the U.S. The company forecasts potential revenue from the WRAPSODY device ranging from $2 million to $4 million for the year 2025, supported by promising clinical efficacy data.
Read more →MMSIMerit Medical Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula (AVF) Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial
Merit Medical Systems announced positive 24-month efficacy results from the randomized AVF arm of the WAVE trial, which evaluated the WRAPSODY CIE device for restoring vascular access in hemodialysis patients. The results showed significantly higher TLPP and ACPP rates for the WRAPSODY CIE compared to PTA. The findings were presented at the VIVA conference and indicate the device's potential to extend functional vascular access.
Read more →MMSIMerit Medical Releases 24-Month Efficacy Results from the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial
Merit Medical Systems announced positive 24-month efficacy results from the AVG cohort of the WAVE trial, presented at the VEINS conference. The WRAPSODY CIE showed a TLPP of 81.4% at 6 months, surpassing performance goals. The device aims to restore vascular access for hemodialysis patients experiencing complications. The results are expected to assist physicians in patient care.
Read more →MMSI▲ +5.4%on this newsshared move
Merit Medical Reports Third Quarter 2025 Results and Updates Full-Year Guidance
Merit Medical Systems reported a revenue of $384.2 million for Q3 2025, marking a 13.0% increase from the previous year. The company's non-GAAP earnings per share guidance has been raised, reflecting better-than-expected financial performance. Despite a slight decrease in GAAP net income, the CEO expressed confidence in achieving growth and profitability amid potential risks from trade policies.
Read more →MMSIMerit Medical Signs Asset Purchase Agreement with PENTAX Medical to Acquire C2 CryoBalloon Technology
Merit Medical Systems has signed an asset purchase agreement with PENTAX Medical to acquire the C2 CryoBalloon technology, aimed at enhancing treatment for gastrointestinal disorders. The deal, valued at $22 million, is expected to close in Q4 2025 and will integrate the C2 technology into Merit's existing Endoscopy portfolio. While the acquisition is projected to dilute earnings initially, it is anticipated to contribute significantly to revenue in the future.
Read more →MMSIMerit Medical Systems to Announce Third Quarter 2025 Results on October 30, 2025
Merit Medical Systems, Inc. will announce its financial results for Q3 2025 on October 30, 2025. The results will be released after market close, followed by an investor conference call at 5:00 p.m. Eastern. Interested parties can pre-register for the call and access a live webcast on the company's website.
Read more →MMSIMerit Medical Announces SCOUT Milestone: 750,000 Patients Treated with Wire-Free Technology
Merit Medical Systems has announced a significant milestone with its SCOUT Radar Localization technology, which has successfully treated 750,000 patients globally. This achievement coincides with Breast Cancer Awareness Month, highlighting the importance of early detection and effective treatment options. The SCOUT system enhances surgical precision and is increasingly recognized in clinical settings, further supporting breast cancer care.
Read more →MMSIMerit Medical Embosphere Microspheres Achieve CE Mark for Genicular Artery Embolisation to Treat Knee Osteoarthritis
Merit Medical Systems has announced that its Embosphere Microspheres have received CE Mark approval for use in genicular artery embolisation (GAE) to treat knee osteoarthritis in the EU. This non-surgical procedure aims to reduce blood flow to the inflamed joint, providing significant pain relief and improved mobility. Clinical data indicates that over 75% of patients experienced sustained pain reduction for up to 24 months. The approval highlights the growing trend towards minimally invasive therapies in pain management.
Read more →MMSIGrowing Excellence: Miguel López, Merit Garden Coordinator<br/><span style="color: #C9252C;">Employee Highlight</span>
Miguel López, the Merit Garden Coordinator, manages the greenhouse and employee garden at Merit Medical. He focuses on sustainable farming and fosters a sense of community among employees through gardening activities. Miguel also shares his culinary skills by making salsa from garden produce. His dedication to improving employee wellness and expanding his gardening knowledge is evident.
Read more →MMSI3 Ways Merit Medical Strives to Bring Excellence to the Customer Experience
Merit Medical, founded in 1987, focuses on excellence in customer experience as part of its updated Vision and Values. The company emphasizes collaboration across departments to enhance product quality and patient care. Key initiatives include a unified quality management system and ongoing communication with stakeholders to ensure successful clinical trials and product launches.
Read more →MMSIFirst Patient Enrolled in Merit Medical’s WRAPSODY (WRAP) North America Registry
Merit Medical Systems has enrolled the first patient in the WRAP North America registry, which aims to evaluate the WRAPSODY CIE device for patients on hemodialysis with vascular access obstructions. The registry plans to enroll up to 250 patients in the US and Canada over three years. This initiative follows the device's prior clinical successes and aims to enhance patient care in dialysis.
Read more →MMSIMerit Medical Launches the Prelude Wave Hydrophilic Sheath Introducer with SnapFix Technology
Merit Medical Systems, Inc. has launched the Prelude Wave Hydrophilic Sheath Introducer featuring SnapFix Securement Technology. This new product aims to enhance patient outcomes during radial access procedures by reducing risks of arterial spasm and occlusion. The Prelude Wave boasts improved lubricity and requires less insertion force, making it a significant advancement in Merit’s Access portfolio.
Read more →MMSIMerit Medical Reports Second Quarter 2025 Results and Updates Full-Year Guidance
Merit Medical Systems, Inc. reported strong financial results for the second quarter of 2025, with revenue of $382.5 million, marking a 13.2% increase year-over-year. The company achieved a non-GAAP EPS of $1.01, up 9.8%, although GAAP EPS dropped by 11.6% to $0.54 compared to the same quarter last year. Due to better-than-expected performance, Merit has raised its full-year revenue and EPS guidance. The company also highlighted significant free cash flow generation and a recent acquisition of Biolife Delaware, LLC.
Read more →MMSIAt the HEART of Sustainability: A Look at Our 2024 Progress
Merit Medical highlights its sustainability progress for 2024, driven by its HEART values: Health, Excellence, Agility, Responsibility, and Teamwork. The company has made significant strides in reducing its environmental footprint, including a notable increase in renewable energy usage and waste reduction. Additionally, Merit emphasizes employee wellness and community engagement, showcasing its commitment to a sustainable future.
Read more →MMSIMerit Medical Names Martha Aronson as New President and Chief Executive Officer
Merit Medical Systems, Inc. has appointed Martha Aronson as its new President and CEO, effective October 3, 2025, succeeding Fred Lampropoulos, who will continue as Chairman of the Board. Aronson brings extensive experience in global healthcare, having previously held significant leadership roles at Ecolab and Medtronic. The company also announced strong preliminary revenue results for Q2 2025, projecting an increase of 12% to 14% compared to the previous year. Lampropoulos expressed his confidence in Aronson's leadership as the company enters its next growth phase.
Read more →MMSIMerit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025
Merit Medical Systems, Inc. is set to announce its financial results for the second quarter of 2025 on July 30, 2025. The release will take place after the market closes, followed by an investor conference call at 5:00 p.m. Eastern time. This event demonstrates the company’s commitment to transparency and engagement with its investors.
Read more →MMSIPutting it into Practice: Why Continuing Medical Education is Vital to Improving Patient Care
The article discusses the importance of continuing medical education (CME) in enhancing patient care. It highlights the role of the Think Education program in providing physicians with up-to-date knowledge and skills through innovative courses. These educational opportunities allow physicians to implement the latest techniques and improve patient outcomes. The program emphasizes collaboration and the sharing of expertise among medical professionals.
Read more →MMSIMerit Medical Names Martha Aronson as New President and Chief Executive Officer Fred Lampropoulos will continue to serve as Chairman of Merit's Board of Directors Merit announces preliminary unaudited revenue for the qua
Merit Medical Systems, Inc. has announced the appointment of Martha Aronson as the new President and CEO, effective October 3, 2025, while Fred Lampropoulos will continue as Chairman. The company also reported preliminary unaudited revenue between $380 to $384 million for the quarter ending June 30, 2025, marking a projected increase of approximately 12% to 14% compared to the previous year. Aronson's extensive experience in global healthcare is expected to drive Merit's future success as it enters this new chapter.
Read more →MMSIOur Support for Men’s Health
Merit Medical highlights its commitment to men's health during June, focusing on conditions like benign prostatic hyperplasia (BPH), heart disease, and gastroesophageal reflux disease (GERD). The company offers advanced treatment options, including prostatic artery embolization and cardiac resynchronization therapy, alongside educational resources for patients and healthcare providers. Their initiatives aim to improve awareness and care for men's health issues.
Read more →MMSIMerit Medical Employee Innovators – Rachel Oberg
Merit Medical's Rachel Oberg, a Manager of R&D, highlights her innovations, particularly the WRAPSODY Cell-Impermeable Endoprosthesis. This device addresses vascular obstructions, especially in patients with end-stage kidney disease. Oberg's work focuses on developing a biocompatible PTFE coating to enhance the device's effectiveness and patient outcomes. Her journey reflects a commitment to improving dialysis care through innovative solutions.
Read more →MMSIMerit Medical Acquires Biolife Delaware, L.L.C.
Merit Medical Systems, Inc. has successfully acquired Biolife Delaware, L.L.C., enhancing its portfolio of hemostatic products with StatSeal and WoundSeal. This acquisition is expected to increase Merit's annual revenues by approximately $18 million starting 2026. While projected to be slightly dilutive to full-year 2025 profitability, it positions Merit to capitalize on a substantial global market opportunity. The acquisition was finalized for $120 million in cash and liabilities, thereby solidifying Merit's commitment to expanding its innovative healthcare solutions.
Read more →MMSIPR/Media Inquiries: Sarah Comstock Merit Medical Investor Inquiries: Mike Piccinino, CFA, IRC ICR Healthcare +1-801-432-2864 +1-443-213-0509 sarah.comstock@merit.com mike.piccinino@icrhealthcare.com Merit Medic
Merit Medical Systems, Inc. has announced the acquisition of Biolife Delaware, L.L.C. for approximately $120 million, making Biolife a wholly-owned subsidiary. This acquisition is anticipated to enhance Merit's portfolio of hemostatic solutions, particularly in vascular closure and catheter bleeding complications. The transaction is projected to provide an estimated $10 to $11 million in revenue through the end of 2025, albeit with some dilution to non-GAAP profitability in the short term. Despite this initial impact, the company expects this acquisition to positively contribute to growth in the following years.
Read more →MMSIMerit Medical Announces Health Canada Approval of the WRAPSODY Cell-Impermeable Endoprosthesis
Merit Medical Systems, Inc. announced that its WRAPSODY Cell-Impermeable Endoprosthesis (CIE) has received regulatory approval from Health Canada. This approval enables the immediate commercialization of the device in Canada, aimed at improving vascular access for hemodialysis patients. Clinical trial data support its effectiveness, showing significantly higher primary patency rates against existing treatments. The WRAPSODY CIE's unique tri-layer design is intended to overcome past challenges in vascular access devices.
Read more →MMSIMerit Medical Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY Arteriovenous Efficacy (WAVE) Trial
Merit Medical Systems, Inc. announced the 12-month efficacy results of the WRAPSODY Arteriovenous Graft (AVG) device from the WAVE trial. The trial included 112 patients, revealing a TLPP of 81.4% at 6 months, well above the performance target of 60%. Key findings were shared during the Charing Cross Symposium, emphasizing potential benefits for patients with limited options for AVG restoration. However, a notable decline in TLPP was observed at 12 months, dropping to 60.2%.
Read more →MMSI6 Ways Merit Promotes Psychological Safety in the Workplace
Merit is actively promoting psychological safety and mental health awareness among its employees during Mental Health Awareness Month. The company offers various resources, including free counseling sessions, wellness talks, a meditation room, and nutrition programs. These initiatives aim to create a supportive work environment that values employee well-being and encourages healthy lifestyles.
Read more →MMSIMerit Medical Reports First Quarter 2025 Results and Updates Full-Year Guidance
Merit Medical Systems, Inc. reported its first-quarter 2025 results, highlighting a revenue of $355.4 million, marking a 9.8% increase from the previous year. Strong performance was noted in both constant currency revenue and non-GAAP earnings per share, which experienced substantial growth year-over-year. Despite reaffirming revenue guidance for the fiscal year 2025, the company lowered its EPS guidance, citing the potential effects of new trade policies. Additionally, while gross margins improved, the decline in free cash flow and the company's high debt levels are notable concerns.
Read more →MMSI▲ +8.3%on this news
Merit Medical Launches the Ventrax™ Delivery System
Merit Medical Systems, Inc. has officially launched the Ventrax Delivery System, designed to improve cardiac interventions, specifically for treating ventricular tachycardia. This innovative system provides a streamlined approach for catheter placement via retrograde aortic access, which is crucial for accessing the left ventricle during procedures. The launch reflects a response to the urgent need for effective tools in VT ablation, an area of growing interest among healthcare professionals. Experts have praised the new system for its potential to enhance patient outcomes significantly.
Read more →MMSIMerit Medical Systems to Announce First Quarter 2025 Results on April 24, 2025
Merit Medical Systems, Inc. will announce its first quarter 2025 financial results on April 24, 2025, after market close. The company will also conduct an investor conference call on the same day at 5:00 p.m. Eastern. Founded in 1987, Merit Medical specializes in creating medical devices for various medical procedures and serves customers worldwide with a robust workforce.
Read more →MMSIMerit Medical Releases 12-Month Efficacy Results of the WRAPSODY Cell-Impermeable Endoprosthesis (CIE)
Merit Medical Systems, Inc. announced positive 12-month efficacy results for its WRAPSODY Cell-Impermeable Endoprosthesis (CIE) as part of the WAVE trial. Results showed a significant improvement in target lesion and access circuit primary patency compared to standard treatments. The WRAPSODY CIE continues to demonstrate its potential to enhance vascular access for patients undergoing hemodialysis by addressing stenosis issues effectively. The trial findings will be published and presented at upcoming industry meetings, further promoting the device's advantages.
Read more →MMSIMerit Medical Rings Nasdaq Opening Bell to Celebrate 35-Year Partnership
Merit Medical Systems, Inc. is set to celebrate its 35th anniversary of being listed on the Nasdaq by ringing the opening bell on March 19, 2025. The ceremony will be attended by Chairman and CEO Fred Lampropoulos, who emphasized the significant milestone and the strong partnership with Nasdaq. Founded in 1987, Merit Medical specializes in medical devices across various fields including cardiology and oncology, employing around 7,400 individuals worldwide.
Read more →MMSILifting Voices: The Women’s Leadership Initiative at Merit EMEA
Merit Medical's Women's Leadership Initiative (WLI) aims to foster inclusivity and professional growth by providing leadership opportunities and training sessions. The initiative, which is open to all genders, emphasizes collaboration and diverse perspectives, enhancing innovation within the organization. It also promotes health and wellness through various activities and resources, contributing to a supportive work environment.
Read more →MMSIMerit Medical Reports Fourth Quarter and Full Year 2024 Results and Issues Fiscal Year 2025 Guidance
Merit Medical Systems, Inc. reported strong financial results for the fourth quarter and fiscal year 2024, with revenue and non-GAAP EPS both showing substantial growth. The company achieved a fourth quarter revenue of $355.2 million, an increase of 9.4% from the prior year, and a full year revenue of $1.357 billion, up 7.9%. Non-GAAP EPS for the fourth quarter reached $0.93, marking a 25.8% increase. Looking ahead, Merit provided fiscal year 2025 guidance, projecting revenue between $1.470 billion and $1.490 billion, indicating confidence in continued growth.
Read more →MMSIMerit Medical Employee Innovators – Christopher Cindrich
Merit Medical's Principal Engineer, Christopher Cindrich, discusses his innovative vascular prosthesis deployment device designed for dialysis patients. This device addresses issues like stenoses and occlusions in dialysis outflow circuits, improving treatment and patient quality of life. Cindrich emphasizes the importance of problem-solving in medical device design.
Read more →MMSIExcellence in Operation: The Merit Richmond Story
Merit Richmond is highlighted as a model of operational excellence within Merit. The facility produces over 32,000 medical kits and trays weekly, showcasing efficient and innovative practices. Employee engagement is prioritized through open communication and team activities, contributing to a positive workplace culture. The commitment to excellence is evident in both operations and employee satisfaction.
Read more →MMSIMerit Medical Systems Wrapsody Investor Conference Call Remarks Operator: Please standby. Welcome to the Merit Medical Systems Wrapsody Investor Conference Call. At this time, all participants have been placed in listen-
Merit Medical Systems held a conference call discussing the recent approval and launch of its WRAPSODY Cell-Impermeable Endoprosthesis. The device received premarket approval from the FDA, allowing for its use in treating patients in the U.S. starting in early January. CEO Fred Lampropoulos highlighted this achievement as part of a long-term strategic initiative begun in 2010, aimed at developing higher-value medical devices. The call featured insights from Dr. Danny Patel on clinical uses of the device, emphasizing the potential for future innovation in therapeutic products.
Read more →MMSIPR/Media Inquiries: Sarah Comstock Merit Medical Investor Inquiries: Mike Piccinino, CFA, IRC Westwicke - ICR +1-801-432-2864 +1-443-213-0509 sarah.comstock@merit.com mike.piccinino@westwicke.com FOR IMMEDIATE
Merit Medical Systems, Inc. announced preliminary unaudited revenue for the year ended December 31, 2024, estimating around $1.355 to $1.357 billion, reflecting a projected increase of approximately 7.7% to 7.9% from 2023. The company will also report its FY 2025 guidance and fourth-quarter results on February 25, 2025. In addition to the financial figures, the announcement includes a commitment to utilizing non-GAAP financial measures for better performance insights. However, inherent risks related to financial audits, supply chain disruptions, and integration of acquired products were highlighted.
Read more →MMSIMerit Medical Announces Preliminary Unaudited Revenue for the Year Ended December 31, 2024 and Plans to Announce Fourth Quarter and Year End 2024 Results and Issue Fiscal Year 2025 Guidance on February 25, 2025
Merit Medical Systems, Inc. has announced preliminary unaudited revenue for the year ended December 31, 2024, projecting an increase of approximately 7.7% to 7.9% year-over-year, amounting to about $1.355 billion to $1.357 billion. The company also reported a constant currency revenue increase of approximately 8.4% to 8.6%. Financial results for Q4 2024 and guidance for fiscal year 2025 will be released on February 25, 2025, along with an investor conference call.
Read more →MMSIMerit Medical Announces FDA Approval of the WRAPSODY Cell-Impermeable Endoprosthesis
Merit Medical Systems, Inc. announced that its WRAPSODY Cell-Impermeable Endoprosthesis has received FDA premarket approval, allowing for commercialization starting in 2025. This innovative device aims to improve long-term vessel patency in dialysis patients, who often face complications from vascular access sites. Clinical trial results indicated promising primary patency rates for both arteriovenous fistula and graft patients. An informational call is scheduled for January 28, 2025, to discuss future opportunities related to the device.
Read more →MMSIPR/Media Inquiries: Sarah Comstock Merit Medical +1-801-432-2864 sarah.comstock@merit.com Merit Medical Announces Resignation of President, Joseph Wright
Merit Medical Systems, Inc. announced the resignation of its President, Joseph C. Wright, effective January 3, 2025. This decision comes after the company received notice of allegations regarding Mr. Wright's conduct, although these allegations were stated to be unrelated to the company's operations or financial performance. Following his resignation, Fred P. Lampropoulos has been re-appointed as President. The situation raises potential concerns regarding leadership stability and could affect employee morale.
Read more →MMSIMerit Medical Announces Resignation of President, Joseph Wright
Merit Medical Systems, Inc. announced the resignation of its President, Joseph C. Wright, effective January 3, 2025. His resignation follows allegations regarding his conduct, which the independent directors investigated, although the company specified that these allegations were unrelated to its operations or financial performance. Fred P. Lampropoulos has been re-appointed as President by the Board of Directors. The company is recognized for developing and distributing medical devices used in various therapeutic and diagnostic procedures.
Read more →MMSIMerit Medical’s WRAPSODY WAVE Trial Exceeds Performance Goals for Arteriovenous Graft (AVG) Patients
Merit Medical Systems, Inc. announced encouraging results from the six-month findings of its WAVE trial, focusing on its WRAPSODY device for arteriovenous graft patients. The trial reported an efficacy rate of 81.4%, significantly surpassing the performance goal of 60%. Additionally, the device demonstrated a safety outcome where 95.4% of patients experienced no adverse events. These results were presented at the VEITHsymposium, highlighting the potential benefits for patients undergoing hemodialysis.
Read more →MMSIMerit Galway Celebrates the Importance of STEM within the Community
Merit Galway celebrates STEM Day by highlighting its initiatives to promote STEM education in the community. The company partners with the Youth Academy to provide scholarships and supports the Galway Science & Technology Festival. These efforts aim to inspire students and prepare them for future careers in STEM fields. Additionally, Merit Galway hosts facility visits for students to experience real-world applications of STEM.
Read more →MMSIPR/Media Inquiries: Sarah Comstock Merit Medical Investor Inquiries: Mike Piccinino, CFA, IRC Westwicke - ICR +1-801-432-2864 +1-443-213-0509 sarah.comstock@merit.com mike.piccinino@westwicke.com Merit Medical
Merit Medical Systems, Inc. has successfully completed the acquisition of Cook Medical's lead management portfolio for approximately $210 million. This strategic move aims to strengthen Merit's position in the growing electrophysiology and CRM market. The acquisition is expected to enhance the offerings of medical devices for cardiac rhythm disorders. Merit's CEO expressed optimism about the future, emphasizing the added talent and resources from Cook Medical.
Read more →MMSIMerit Medical Completes Acquisition of Lead Management Portfolio from Cook Medical
Merit Medical Systems, Inc. has completed the acquisition of Cook Medical's lead management portfolio for approximately $210 million. This strategic move aims to bolster Merit's capabilities in the electrophysiology and cardiac rhythm management sectors. By integrating Cook's lead management business, Merit expects to strengthen its offerings for patients requiring heart medical devices. The financial implications of this acquisition were detailed in Merit’s recent earnings report.
Read more →MMSIMerit Medical Reports Third Quarter 2024 Results and Raises Full-Year Guidance
Merit Medical Systems, Inc. announced its third-quarter financial results for 2024, reporting revenues of $339.8 million, representing a 7.8% year-over-year increase. The company also provided an updated financial guidance for the full year, anticipating net sales of $1.344 to $1.352 billion. Recent acquisitions, including assets from EndoGastric Solutions and Cook Medical, are expected to further contribute to the company's growth. Furthermore, the positive findings from a pivotal trial related to its Wrapsody Endoprosthesis device are noteworthy, despite the device not being commercially available in the U.S. yet.
Read more →MMSIWhy SCOUT® Radar Localization?
Merit Medical highlights its SCOUT Radar Localization technology during Breast Cancer Awareness Month. This innovative system aids in the surgical removal of abnormal breast tissue while minimizing damage to healthy tissue. SCOUT's tiny reflector allows for precise localization within 1 mm, enhancing treatment outcomes for breast cancer patients. The technology has been used in nearly 600,000 procedures worldwide.
Read more →MMSIMerit Medical Systems to Announce Third Quarter 2024 Results on October 30, 2024
Merit Medical Systems, Inc. has announced it will release its financial results for Q3 2024 on October 30, 2024, after market close. An investor conference call is scheduled for the same day at 5:00 p.m. Eastern time, allowing for discussions on the company's performance. Merit Medical, established in 1987, specializes in medical devices across various healthcare sectors and employs around 7,200 people globally.
Read more →MMSITogether Caring for Community Health: A Look at Merit Tijuana’s Environmental Efforts
Merit Medical emphasizes community health and environmental wellness through various initiatives. Their Tijuana facility leads efforts such as beach clean-ups, reforestation at Morelos Park, and recycling programs that support childhood cancer treatments. These activities reflect the company's commitment to creating a healthier environment and inspiring positive community actions.
Read more →MMSIMerit Medical Signs Agreement to Purchase Lead Management Portfolio from Cook Medical
Merit Medical Systems, Inc. has announced a definitive agreement to acquire Cook Medical's lead management portfolio for approximately $210 million. This acquisition is expected to add about $40 million in annual revenue starting in fiscal year 2025 and strengthens Merit's electrophysiology and cardiac rhythm management business. While the transaction is anticipated to be dilutive to non-GAAP profitability in the short term, Merit reaffirms its financial guidance for 2024, including positive projections related to the acquisition. The closing is expected in Q4 2024, pending regulatory approvals.
Read more →MMSIMerit Medical’s WRAPSODY WAVE Trial Demonstrates Superior Patency versus Standard of Care in AV Fistula Patients
Merit Medical Systems, Inc. announced positive six-month results from the AV fistula arm of its WRAPSODY WAVE trial at a European conference. The data reveals a significant improvement in target lesion primary patency for patients using WRAPSODY, compared to those receiving standard care. The company emphasizes these findings as a potential new standard of care for dialysis patients requiring vascular access. However, the device is still under investigation and not yet commercially available in the U.S.
Read more →MMSIMerit Medical to Present at the 2024 Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual Congress
Merit Medical Systems, Inc. announced its participation in the 2024 CIRSE Annual Congress in Lisbon, where it will present pivotal updates from two key studies. The company's focus includes clinical outcomes from the WAVE study and methodology from the MOTION study. Additionally, Merit will sponsor symposia on topics related to treating synovial arterial hypervascularity in the knee and maintaining long-term patency in hemodialysis patients. The event aims to facilitate discussions among interventional radiologists and healthcare providers.
Read more →MMSIAlways Growing: Announcing an Expansion to the Merit Medical Employee Garden
Merit Medical is expanding its Employee Garden at the Salt Lake facility in 2024, aiming to enhance access to fresh produce for employees. The expansion will include a larger growing area, a gazebo for events, and a kids' gardening area. This initiative supports employee wellness and fosters community by providing free produce and encouraging family participation.
Read more →MMSIPR/Media Inquiries: Teresa Johnson Merit Medical Investor Inquiries: Mike Piccinino, CFA, IRC Westwicke - ICR +1-801-208-4295 +1-443-213-0509 tjohnson@merit.com mike.piccinino@westwicke.com FOR IMMEDIATE RELEAS
Merit Medical Systems, Inc. (MMSI) announced strong financial results for the second quarter of 2024, including a 5.6% increase in revenue compared to the same period last year, reaching $338 million. The company exceeded its revenue expectations and reported significant year-over-year improvements in gross and operating margins. Additionally, Merit generated over $80 million in free cash flow during the first half of 2024. Looking ahead, the company has raised its full-year financial guidance, reflecting the robust performance and recent acquisitions impacting future growth.
Read more →MMSIMerit Medical Reports Second Quarter 2024 Results and Raises Full-Year Guidance
Merit Medical Systems, Inc. reported a 5.6% increase in revenue for Q2 2024, reaching $338.0 million. The company experienced significant earnings growth, with GAAP EPS rising by 75.7%. Due to stronger-than-expected results, Merit has raised its full-year guidance, anticipating net sales between $1.335 billion and $1.345 billion. Additionally, the FDA application for the Wrapsody Cell-Impermeable Endoprosthesis device has been submitted. While overall financial progress is encouraging, concerns about high debt levels and acquisition impacts remain.
Read more →MMSIMerit Medical to Present 6-Month Outcomes from Randomized Arm of WRAPSODY™ Arteriovenous Access Efficacy (WAVE) Pivotal Study at Two Upcoming Medical Meetings
Merit Medical Systems, Inc. is set to present findings from its WAVE study, focusing on the WRAPSODY Cell-Impermeable Endoprosthesis designed for treating stenosis in arteriovenous access. Six-month safety and efficacy outcomes will be revealed at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) meeting in Lisbon and later at a symposium in Washington, DC. This pivotal study aims to provide valuable data to improve care for hemodialysis patients, with the device currently under investigation for regulatory approval in the United States. Merit aims to demonstrate the device's efficacy to support its PMA application with the FDA.
Read more →MMSI5 Ways the Merit Care Clinic Fuels Summer Wellness
The Merit Care Clinic supports summer wellness for employees and their families by offering various health services, including primary care visits, skin cancer checks, and nutrition counseling. Special events like 'Food is Medicine' aim to promote healthy eating habits. Additionally, the clinic provides mental health support and prepares children for the upcoming school year with vision screenings and vaccines.
Read more →MMSIMerit Medical Announces Asset Purchase Agreement with EndoGastric Solutions, Inc.
Merit Medical Systems, Inc. has announced an asset purchase agreement with EndoGastric Solutions, Inc. for approximately $105 million, aimed at enhancing its endoscopy portfolio. The acquisition includes the EsophyX Z+ device, which offers a minimally invasive treatment for patients with chronic gastroesophageal reflux disease (GERD). Merit anticipates this addition could generate about $30 million in annual revenue and reaffirms its financial guidance for 2024, while noting some dilution to profitability in the short term. The EsophyX Z+ device is expected to significantly improve patient care in the gastrointestinal field.
Read more →MMSIMerit Medical Systems to Announce Second Quarter 2024 Results on August 1, 2024
Merit Medical Systems, Inc. announced it will release its financial results for the second quarter of 2024 on August 1, 2024. The company will host an investor conference call on the same day to discuss the results. Founded in 1987, Merit specializes in developing and distributing medical devices used in various therapeutic and diagnostic procedures globally.
Read more →MMSIThe Power of Momentum: Merit Medical Releases 2023 Sustainability Report
Merit Medical has released its 2023 Sustainability Report, highlighting progress toward its 2030 Operational Sustainability Goals. The report showcases improvements in renewable energy use, reductions in greenhouse gas emissions, and initiatives aimed at minimizing environmental impact. Additionally, the company emphasizes employee wellness and community engagement as part of its mission to enhance healthcare.
Read more →MMSIMerit Medical Launches basixSKY™ Inflation Device
Merit Medical Systems, Inc. has announced the US commercial release of its new basixSKY Inflation Device. This launch expands the company's portfolio of inflation devices, offering a user-friendly design aimed at improving efficiency in endovascular interventions. The basixSKY can be used independently or in conjunction with Merit’s Angioplasty Packs and other hemostasis valves. With an increasing number of coronary balloon and stent placement procedures anticipated in the U.S., Merit aims to maintain its leadership in the inflation device market.
Read more →MMSIMerit Medical Shareholders Elect Silvia M. Perez as New Director Experienced healthcare veteran brings a broad background spanning clinical, regulatory, operations, marketing, and business leadership to Merit's Board of
On May 15, 2024, Merit Medical Systems, Inc. announced the election of Silvia M. Perez as a new director during their Annual Meeting of Shareholders. Perez, an experienced healthcare veteran with over two decades in the industry, brings expertise in clinical, regulatory, and operational leadership. She has held prominent positions at 3M Company and holds a pharmaceutical chemist degree. The board also re-elected Fred P. Lampropoulos and Stephen C. Evans for three-year terms, marking a continued commitment to strong leadership at Merit Medical.
Read more →MMSIMerit Medical Executive Leadership Team Update Joe Wright Appointed President Expands Deep Bench of Leadership Team Talent; Supports "Continued Growth Initiatives" Program
Merit Medical Systems, Inc. has appointed Joe Wright as President, effective immediately. Wright, who has been with the company for nearly two decades, will oversee the global commercial, marketing, and manufacturing operations. His prior experience includes significant roles such as Chief Commercial Officer and President of Merit's International Division. The company is also continuing its search for a new CEO ahead of the planned retirement of current Chairman and CEO Fred P. Lampropoulos in 2025.
Read more →MMSIMerit Medical Executive Leadership Team Update
Merit Medical Systems, Inc. has appointed Joe Wright as President, with immediate effect. Wright, who has been with the company for 19 years, will oversee global commercial, marketing, and manufacturing operations. His leadership is expected to bolster Merit’s growth initiatives and enhance the company’s international presence. The Board of Directors is also in the process of finding a successor for the retiring CEO, Fred P. Lampropoulos, by the end of 2025.
Read more →MMSIMerit Medical Expands Embolics Portfolio with New Siege™ Vascular Plug and Bearing nsPVA Express™ Prefilled Syringe
Merit Medical Systems, Inc. has received FDA 510(k) clearance for its new Siege Vascular Plug and launched the Bearing nsPVA Express Prefilled Syringe in the US and Australia. These products enhance Merit's position in embolotherapy, providing advanced solutions for vascular occlusion procedures. Both products will be showcased at the 18th Annual GEST Meeting in New York City, aimed at demonstrating their utility in clinical practices. Experts have highlighted the benefits of rapid occlusion and ease of use that these innovations bring to interventional radiology.
Read more →MMSIHighlights of SIR 2024 in Salt Lake City
The Society of Interventional Radiology (SIR) annual meeting took place in Salt Lake City, where Merit showcased innovative products and engaged with physicians. The event featured educational sessions on pressing interventional radiology topics and a networking evening at Merit's headquarters. The company expressed gratitude to SIR and looks forward to the next meeting in Nashville.
Read more →MMSIMerit Medical Reports Results for First Quarter Ended March 31, 2024
Merit Medical Systems, Inc. reported strong financial results for the first quarter of 2024, with revenues of $323.5 million, reflecting an 8.7% increase from Q1 2023. Key metrics showed improvement, including a GAAP EPS of $0.48 and a non-GAAP EPS of $0.77, marking increases of 35.5% and 18.7%, respectively. The company also reaffirmed its financial guidance for the fiscal year 2024, projecting net sales of between $1.312 billion and $1.325 billion, with a predicted growth rate of 4% to 5%. Overall, the results indicate a solid start to the fiscal year, showcasing Merit Medical's ability to drive growth and profitability.
Read more →MMSIBuilding Better Healthcare: The Merit Medical Story
Merit Medical, founded in 1987, has grown from a small operation in Utah to a billion-dollar global company. With a focus on innovation, the company has expanded its manufacturing capabilities worldwide and has received numerous accolades for its products and workplace culture. Merit continues to prioritize customer needs and improve patient care through its diverse offerings.
Read more →MMSIMerit Medical Launches the Micro ACE™ Advanced Micro-Access System
Merit Medical Systems, Inc. announced the commercial release of the Micro ACE Advanced Micro-Access System, which has received FDA clearance. This system aims to enhance interventional procedures that require micro-access, pivotal for addressing atherosclerosis-related conditions. The Micro ACE features a unique design that balances stiffness and flexibility, offering significant resistance to kink and improved visibility under fluoroscopy. Merit Medical also plans to pursue CE mark designation for the Micro ACE and aims to secure patents for the technology both in the U.S. and internationally.
Read more →MMSIMerit Medical Systems to Announce First Quarter 2024 Results on April 30, 2024
Merit Medical Systems, Inc. announced that it will release its financial results for the first quarter of 2024 on April 30, 2024. Following the results announcement, an investor conference call is scheduled for the same day to discuss the outcomes. The company, founded in 1987, specializes in producing medical devices used in various therapeutic and diagnostic procedures and has a diverse global market presence.
Read more →MMSIMerit Medical to Host Evening of Innovation during the 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting
Merit Medical Systems, Inc. announced it will host an Evening of Innovation during the 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting. The event will feature presentations from notable interventional radiologists and a facility tour at Merit’s headquarters. Key educational sessions include procedures addressing vascular access, vertebral augmentation, and patient selection in interventional radiology. Merit emphasizes its dedication to advancing educational opportunities in the field.
Read more →MMSIMerit Medical Introduces “Continued Growth Initiatives” Program and Financial Targets for Three-Year Period Ending December 31, 2026
Merit Medical Systems, Inc. has launched its Continued Growth Initiatives Program alongside financial targets for 2026, aiming for a revenue increase at a CAGR of 5% to 7%. The company expects a non-GAAP operating margin of 20% to 22% and plans to generate at least $400 million in free cash flow over the next three years. These initiatives will be further discussed in an upcoming investor conference call. While the goals are optimistic, Merit acknowledges potential uncertainties related to various financial impacts.
Read more →MMSIMerit Medical Reports Results For Fourth Quarter and Year Ended December 31, 2023 - Issues Fiscal Year 2024 Guidance
Merit Medical Systems, Inc. (NASDAQ: MMSI) announced robust financial results for the fourth quarter and fiscal year 2023, reporting a revenue increase of 10.6% year-over-year. The company also experienced improvements in non-GAAP operating margins and generated significant free cash flow. For fiscal year 2024, Merit anticipates stable revenue growth and increasing profitability, providing guidance of $1.312 to $1.325 billion in sales. Despite a decline in GAAP EPS and a rise in total debt obligations, the overall financial outlook remains strong.
Read more →MMSIMerit Medical Receives FDA 510(k) Clearance for SCOUT MD™ Surgical Guidance System
Merit Medical Systems, Inc. has received FDA 510(k) clearance for its SCOUT MD Surgical Guidance System, marking a significant advancement in breast cancer treatment. This system aims to enhance the precision of tumor excision by employing multiple reflector configurations, potentially leading to improved patient outcomes and reduced need for repeat surgeries. The development aligns with Merit's ongoing leadership in oncology and reflects their commitment to innovative solutions in healthcare. Notably, Merit has already distributed over 500,000 devices to hospitals worldwide, gathering valuable feedback to further drive advancements in cancer care.
Read more →MMSIMerit Medical Partners with American Heart Association to Help Save Lives
Merit Medical has partnered with the American Heart Association to promote hands-only CPR during Heart Month, coinciding with the Association's 100th anniversary. The initiative aims to educate the public on the importance of CPR in saving lives during cardiac emergencies. Various events, including CPR training and health checks, are scheduled throughout February.
Read more →MMSIInnovation & Education at SIR 2024
Merit Medical will exhibit at the SIR 2024 Annual Scientific Meeting in Salt Lake City, UT, from March 23 to 28. The event will feature educational programs, hands-on workshops, and an evening event with CEO Fred Lampropoulos discussing the future of interventional radiology devices. Attendees can also learn about innovative products like the TEMNO Elite Biopsy System and BioSentry Tract Sealant System.
Read more →MMSIBusiness Excellence: How Vertical Integration Puts the “Hero” in HeRO® Graft
Merit Medical Systems emphasizes business excellence through vertical integration, particularly in the production of ePTFE, a key material for the HeRO Graft. This strategy ensures better control over supply chains and product quality, ultimately benefiting healthcare partners and patients. The HeRO Graft provides essential hemodialysis access for patients with renal disease, improving their quality of life.
Read more →MMSIMerit Medical Announces Projected Preliminary Unaudited Revenue for the Year Ended December 31, 2023 and Plans to Announce Fourth Quarter and Year End 2023 Results and Issue Fiscal Year 2024 Guidance on February 28, 2024
Merit Medical Systems, Inc. has announced projected preliminary unaudited revenue for the year ending December 31, 2023, estimated between $1.255 billion and $1.259 billion, reflecting a year-over-year increase of approximately 9.0% to 9.4%. Additionally, the constant currency revenue is anticipated to grow by around 9.6% to 9.9% compared to the previous year. The company plans to disclose its detailed financial results and provide guidance for 2024 on February 28, 2024, during an investor conference call.
Read more →MMSIMerit Medical to Present at the J.P. Morgan 42nd Annual Healthcare Conference
Merit Medical Systems, Inc. will be represented by Chairman and CEO Fred Lampropoulos at the upcoming J.P. Morgan 42nd Annual Healthcare Conference on January 8, 2024. During the presentation, Merit will highlight its ongoing commitment to product innovation aimed at improving patient outcomes. A live audio webcast will be available for investors and interested parties. This event marks a significant opportunity for Merit Medical to showcase its developments in the healthcare technology sector.
Read more →MMSIMerit Medical Reaches Prime Status for ESG Initiatives
Merit Medical has achieved Prime Status from Institutional Shareholder Services (ISS) for its Environmental, Social, and Governance (ESG) initiatives. This recognition reflects the company's commitment to responsible business practices and sustainability. Merit excelled in various ESG areas, including environmental management and employee health, which enhances its appeal to investors and employees alike.
Read more →MMSIMerit Medical Announces Process for Chief Executive Officer Succession Planning
Merit Medical Systems, Inc. has announced its ongoing succession planning for the CEO role, as Founder and CEO Fred Lampropoulos will remain in position until December 31, 2025. A special steering committee of independent directors has been established to oversee the development of this succession plan, aided by Korn Ferry to identify potential candidates. The committee emphasizes the importance of finding a successor who can uphold Merit’s culture while driving innovation and growth.
Read more →MMSIMerit Medical Announces Pricing of Upsized Private Offering of $650.0 Million of 3.00% Convertible Senior Notes Due 2029
Merit Medical Systems, Inc. has announced the pricing of an upsized private offering of $650 million in 3.00% convertible senior notes due in 2029. The offering is expected to generate net proceeds of approximately $630.5 million, which may be used for general corporate purposes, including debt repayment, marketing, and R&D activities. Notably, there is potential for the initial purchasers to exercise an option to purchase additional notes, increasing the net proceeds to approximately $725.1 million.
Read more →MMSIMerit Medical Announces Proposed Private Placement of $550 Million of Convertible Senior Notes
Merit Medical Systems, Inc. has announced a proposed private placement of $550 million in convertible senior notes. The offering, intended for qualified institutional buyers, reflects the company's strategy to raise capital for general corporate purposes, including potential acquisitions, research and development, and debt reduction. However, the outcome is subject to customary closing conditions and actual results may differ from projections outlined in the release. Investors are advised to consider the risks associated with the offering, including market price volatility and the uncertainty of achieving the stated financial expectations.
Read more →MMSIMerit Medical Partners with Jordan PREP, Expanding STEM Education to More Students
Merit Medical has partnered with Jordan PREP to enhance STEM education for students, particularly those from underrepresented backgrounds. The program, which offers a six-week summer curriculum, aims to improve analytical skills and motivate students towards STEM careers. Participants have shown significant academic growth and increased confidence in their abilities. This initiative reflects Merit Medical's commitment to community support and educational advancement.
Read more →MMSIMerit Medical Reports Results for Third Quarter Ended September 30, 2023
Merit Medical Systems, Inc. reported a revenue of $315.2 million for Q3 2023, marking a 9.8% increase from the previous year. The company also demonstrated significant improvements in profitability, with GAAP EPS increasing to $0.44 and non-GAAP EPS rising to $0.75. In light of these results, Merit has raised its fiscal year 2023 financial guidance. The strong performance was attributed to broad growth in key product segments, particularly within the U.S. market.
Read more →MMSIMerit Medical Launches Expanded Maestro Microcatheter Line
Merit Medical Systems has expanded its Maestro Microcatheter line, now offering a longer 165-cm version suitable for radial embolization procedures. This expansion aims to enhance the company's embolotherapy solutions and improve patient outcomes. The new catheter options support various embolization needs and are designed to streamline the treatment process. The radial access method, facilitated by the Maestro, is noted for its benefits including reduced complications and improved patient comfort.
Read more →MMSIMerit Medical Systems to Announce Third Quarter 2023 Results on October 26, 2023
Merit Medical Systems, Inc. announced that it will release its financial results for the third quarter of 2023 on October 26, 2023. The announcement includes details for an investor conference call scheduled for the same day at 5:00 p.m. Eastern. This call will provide insights into the company's performance and future outlook. Interested participants are encouraged to pre-register for the call and access a live webcast to enhance engagement.
Read more →MMSIMile-Markers to Breast Cancer Recovery with SCOUT®: The Tara Zuzga Story
Tara Zuzga's journey through breast cancer highlights the importance of early detection and innovative treatment options like SCOUT Radar Localization. After discovering a mass, she quickly sought medical help and began chemotherapy. Thanks to her proactive approach and the support of her healthcare team, Tara achieved a cancer-free status in January 2022, marking a significant milestone in her recovery.
Read more →MMSIMerit Medical Launches the Aspira Evacuated Drainage Bottle
Merit Medical Systems, Inc. has announced the U.S. commercial launch of its Aspira Bottle, a new addition to its drainage product portfolio. This evacuated drainage bottle is designed for patients suffering from recurring pleural effusions and malignant ascites, offering a more comfortable at-home treatment option. The product is notable for its compact design, requiring 23% less storage space compared to competitors, and enables users to control drainage speed to enhance patient comfort. The introduction of the Aspira Bottle aligns with Merit's commitment to improving patient care and quality of life.
Read more →MMSIMike Voigt, Merit Medical Chief Human Resources Officer, Receives 2023 HR Achievement Award
Mike Voigt, Chief Human Resources Officer at Merit Medical, has been awarded the 2023 HR Achievement Award by Utah Business. This recognition highlights his commitment to creating a positive workplace and fostering employee well-being. Voigt emphasizes the importance of empathy and continuous improvement in his role, reflecting Merit Medical's dedication to excellence.
Read more →MMSIMerit Sensor’s Recycling Initiative Reduces Water Usage by 65%
Merit Sensor has launched a water-conservation initiative that recycles 65% of the water used in manufacturing MEMS pressure sensors. This effort is part of a broader commitment to sustainability, particularly in response to ongoing drought conditions in Utah. The initiative not only reduces water consumption but also improves the quality of wastewater discharged. Merit aims to further enhance this system to recycle up to 90% of water.
Read more →MMSIMerit Medical’s WRAPSODY™ Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment
Merit Medical Systems, Inc. has completed enrollment in its pivotal WAVE study, which evaluates the efficacy of the WRAPSODY Cell-Impermeable Endoprosthesis in treating stenosis and occlusion in patients undergoing hemodialysis. The study involved 357 patients across multiple countries and aims to gather critical safety and efficacy data. Following the study, Merit intends to submit a Premarket Approval application to the FDA within six months. The WRAPSODY device is currently under an Investigational Device Exemption in the U.S. and has received CE Mark approval in the European Union.
Read more →MMSIMerit Medical Reports Results For Second Quarter June 30, 2023
Merit Medical Systems, Inc. (MMSI) reported strong financial results for the second quarter ending June 30, 2023, with revenues reaching $320.1 million, reflecting an 8.5% increase compared to the previous year. The company also saw a significant improvement in profitability, with non-GAAP earnings per share rising to $0.81, up from $0.73 in the prior year. Additionally, Merit updated its financial guidance for the fiscal year 2023, projecting net sales of $1.230 to $1.244 billion, marking a year-over-year growth of 7% to 8%. Overall, the results indicate a positive trajectory in the company's performance.
Read more →MMSIBecoming Fibroid Free: Malin Finds Relief Through UFE
Malin Florentzson, faced with severe fibroid symptoms, sought a second opinion after being advised to undergo a hysterectomy. Discovering uterine fibroid embolization (UFE) as a viable alternative, she successfully underwent the procedure, leading to significant symptom relief. Now, she actively promotes awareness of UFE as a treatment option for fibroids.
Read more →MMSIMerit Medical Systems to Announce Second Quarter 2023 Results On July 25, 2023
Merit Medical Systems, Inc. will announce its financial results for the second quarter of 2023 on July 25, 2023, after market close. An investor conference call is scheduled for the same day at 5:00 p.m. Eastern time. The company, a global leader in healthcare technology, has a substantial workforce and international operations, serving hospitals worldwide. Further details regarding the conference call and webcast will be available through the company's website.
Read more →MMSIMerit Medical Announces Acquisition of Dialysis Catheter Portfolio and the BioSentry Biopsy Tract Sealant System from AngioDynamics, Inc. and Acquisition of the Surfacer Inside-Out Access Catheter System from Bluegrass Vascular Technologies, Inc.
Merit Medical Systems, Inc. has completed acquisitions of a dialysis catheter portfolio and the BioSentry Biopsy Tract Sealant System from AngioDynamics for $100 million, along with the Surfacer Access Catheter System from Bluegrass Vascular for $32.5 million. These acquisitions are anticipated to enhance Merit's product offerings in key strategic markets and generate approximately $30 million in additional annual revenue. Despite the positive outlook, the acquisitions are expected to slightly dilute GAAP earnings in the short term due to increased expenses associated with the transactions.
Read more →MMSIMerit Medical Announces New Five-Year Senior Secured Credit Agreement Credit agreement includes a revolving credit facility of up to $700 million and a term loan facility of up to $150 million
Merit Medical Systems, Inc. announced a new five-year senior secured credit agreement, which includes a revolving credit facility of up to $700 million and a term loan facility of up to $150 million. The company has borrowed approximately $242 million under the new facilities, which are intended for general corporate purposes and to repay existing borrowings. This agreement is expected to enhance Merit's financial position and flexibility, while maintaining its total indebtedness at similar levels. The facilities will mature on June 6, 2028.
Read more →MMSIMerit Medical Reports Results for First Quarter March 31, 2023
Merit Medical Systems, Inc. reported robust financial results for Q1 2023, with revenues reaching $297.6 million, an 8.0% increase from the previous year. The company recorded notable improvements in profitability metrics, with a GAAP operating margin of 8.9% and non-GAAP operating margin of 16.1%. CEO Fred P. Lampropoulos highlighted strong growth in both U.S. and international markets, exceeding their initial expectations. The company has also updated its 2023 financial guidance to reflect positive performance, reinforcing their strategic growth plans.
Read more →MMSIMerit Medical Systems to Announce First Quarter 2023 Results on April 26, 2023
Merit Medical Systems, Inc. has declared its plan to release the financial results for the first quarter of 2023 on April 26, 2023. Following the release, an investor conference call will take place at 5:00 p.m. Eastern. The company has emphasized its global presence and strong workforce in the healthcare technology sector.
Read more →MMSIMerit Medical Launches Expanded SwiftNINJA Steerable Microcatheter Offering
Merit Medical Systems has announced an expansion of its SwiftNINJA Steerable Microcatheter product line, introducing new low-profile and longer length options. The innovative design allows for real-time adjustment of the catheter's tip shape and angle during procedures, which may lead to improved patient outcomes and reduced operational costs. This product is now the only widely offered steerable microcatheter in the U.S., positioning Merit Medical as a leader in this segment of vascular access technology.
Read more →MMSIMerit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2022 Issues Fiscal Year 2023 Guidance
Merit Medical Systems, Inc. announced a revenue increase of 5.4% for Q4 2022, reporting $293.4 million, alongside a rise in non-GAAP earning per share. The company showed an improvement in its operating margins and net income compared to the fourth quarter of 2021. Additionally, Merit introduced financial guidance for fiscal year 2023, projecting further revenue growth and profitability enhancement despite ongoing global challenges. The optimistic outlook reflects management's confidence in the company's operational strategies and execution.
Read more →MMSIMerit Medical Receives FDA Breakthrough Device Designation for the New SCOUT MD™ Surgical Guidance System
Merit Medical Systems, Inc. has received FDA Breakthrough Device Designation for its SCOUT MD Surgical Guidance System, which aims to enhance precision in oncology care for breast and soft tissue cancers. The SCOUT MD system allows surgeons to pinpoint tumor locations more effectively using up to four reflector configurations, potentially reducing the need for repeat surgeries. This designation enables quicker access to the technology, highlighting its significance in improving patient outcomes in cancer treatment. Merit Medical's commitment to innovation in cancer care is underscored by this advancement.
Read more →MMSIMerit Medical Systems to Announce Fourth Quarter and Year End 2022 Results and Issue Fiscal Year 2023 Guidance on February 22, 2023
Merit Medical Systems, Inc. has announced that it will release its financial results for the fourth quarter and year-end of 2022 on February 22, 2023. The company will also provide guidance for fiscal year 2023 during this period. An investor conference call is scheduled for the same day where stakeholders can engage with management. The call will be accessible through pre-registration, highlighting Merit's commitment to transparency with its investors.
Read more →MMSIMerit Medical Launches the basixALPHA™ Inflation Device
SOUTH JORDAN, Utah, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced U.S. commercial release of the basixALPHA™ Inflation Device. The basixALPHA is the latest additi
Read more →MMSIMerit Medical Launches the PreludeSYNC EZ™ Radial Compression Device
SOUTH JORDAN, Utah, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced U.S. commercial release of the PreludeSYNC EZ™ Radial Compression Device. The new device is the
Read more →MMSIIN THE UNITED STATES DISTRICT COURT DISTRICT OF UTAH STEFFEN MAUTE, derivatively on behalf of MERIT MEDICAL SYSTEMS, INC., Plaintiff, SUMMARY NOTICE TO CURRENT MERIT MEDICAL SYSTEMS, INC. vs. STOCKHOLDERS OF DERIVATIVE A
IN THE UNITED STATES DISTRICT COURT STEFFEN MAUTE, derivatively on behalf of MERIT MEDICAL SYSTEMS, INC., Plaintiff, SUMMARY NOTICE TO CURRENT MERIT MEDICAL SYSTEMS, INC. vs. STOCKHOLDERS OF DERIVATIVE ACTION AND SETTLEMENT FRED P. LAMPROPOULOS; RAUL HEARING PARRA; A. SCOTT
Read more →MMSIMerit Medical Announces the Appointment of Joe Wright to Chief Commercial Officer
SOUTH JORDAN, Utah, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced the appointment of Merit’s long-time executive, Joe Wright, as Merit’s Chief Commercial Officer.
Read more →MMSIMerit Medical Reports Results for Quarter Ended September 30, 2022
Q3 2022 reported revenue of $287.2 million, up 7.5% compared to Q3 2021 Q3 2022 constant currency revenue, organic* up 10.5% compared to Q3 2021 Q3 2022 GAAP operating margin of 6.5%, compared to 6.0% in Q3 2021 Q3 2022 non-GAAP operating margin* of 16.1%, compared to 14.8% in
Read more →MMSIMerit Medical Systems to Announce Third Quarter Results on October 26, 2022
SOUTH JORDAN, Utah, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended September 30, 2022, after the cl
Read more →MMSIMerit Medical Launches the TEMNO Elite™ Soft Tissue Biopsy System
SOUTH JORDAN, Utah, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced U.S. commercial release of the TEMNO Elite™ Soft Tissue Biopsy System, the latest addition to Me
Read more →MMSIMerit Medical Launches the Prelude Roadster™ Guide Sheath
New long guide sheath accesses difficult anatomy in the peripheral vasculature, expanding treatment to more patients SOUTH JORDAN, Utah, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare techno
Read more →MMSIMerit Medical Launches SafeGuard Focus Cool™ Compression Device
SOUTH JORDAN, Utah, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced the launch of its SafeGuard Focus Cool™ Compression Device, an innovative addition to its SafeGua
Read more →MMSIMerit Medical Reports Results for Quarter Ended June 30, 2022
Q2 2022 reported revenue of $295.0 million, up 5.2% compared to Q2 2021 Q2 2022 constant currency revenue, organic* up 7.4% compared to Q2 2021 Q2 2022 GAAP operating margin of 7.9%, compared to 3.2% in Q2 2021 Q2 2022 non-GAAP operating margin of 19.1%, compared to 16.3% in Q
Read more →MMSIMerit Medical Launches Smallest and Shortest Configuration of Elation Pulmonary Balloon Dilator to Help Meet Critical Patient Need
SOUTH JORDAN, Utah, July 20, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced U.S. commercial release of the smallest and shortest configuration in its Elation® Pulmonary Ball
Read more →MMSIMerit Medical Systems to Announce Second Quarter Results on July 27, 2022
SOUTH JORDAN, Utah, July 14, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended June 30, 2022, after the close o
Read more →MMSIMerit Medical Celebrates Completion of Xeriscape Landscaping Project
SOUTH JORDAN, Utah, June 29, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today celebrated the completion of a xeriscape landscaping project at its South Jordan headquarters with Utah Gov
Read more →MMSIMerit Medical Reports Results for Quarter Ended March 31, 2022
Q1 2022 reported revenue of $275.4 million, up 10.6% compared to Q1 2021 Q1 2022 constant currency revenue, organic* up 11.3% compared to Q1 2021 Q1 2022 GAAP EPS $0.18, compared to $0.19 in Q1 2021 Q1 2022 non-GAAP EPS* of $0.53, compared to $0.52 in Q1 2021 * Constant curr
Read more →MMSIMerit Medical’s Chief Legal Officer and Corporate Secretary, Brian Lloyd, Receives Corporate Counsel Award from Utah Business Magazine
SOUTH JORDAN, Utah, April 21, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, is proud to announce that Brian G. Lloyd, Merit’s Chief Legal Officer and Corporate Secretary, is a recipient of
Read more →MMSIMerit Medical Announces Chief Operating Officer Transition Ronald A. Frost to Retire After More than 30 Years of Service Neil Peterson, a 27-Year Company Veteran, Appointed
Merit Medical Announces Chief Operating Officer Transition Ronald A. Frost to Retire After More than 30 Years of Service Neil Peterson, a 27-Year Company Veteran, Appointed COO SOUTH JORDAN, Utah, April 21, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a
Read more →MMSIMerit Medical Announces Launch of ReSolve Thoracostomy Tray
SOUTH JORDAN, Utah, April 18, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced the launch of the ReSolve® Thoracostomy Tray. The new tray contains all products needed for perf
Read more →MMSIMerit Medical Systems to Announce First Quarter Results on April 27, 2022
SOUTH JORDAN, Utah, April 13, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
Read more →MMSIMerit Medical Receives FDA Clearance for SCOUT Bx™ Delivery System
SOUTH JORDAN, Utah, April 11, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, has received FDA clearance for the SCOUT Bx™ Delivery System, the first wire-free breast localization solution t
Read more →MMSIMerit Medical Receives FDA “Breakthrough Device Designation” for Embosphere Microspheres for Use in Genicular Artery Embolization for Symptomatic Knee Osteoarthritis
SOUTH JORDAN, Utah, March 07, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), announced today that it has received “breakthrough device designation” from the U.S. Food & Drug Administration (FDA) for Embosphere® Microspheres for the Genicular Artery Embolizat
Read more →MMSIMerit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2021, Issues FY 2022 Guidance
Q4 2021 reported revenue of $278.5 million, up 7.9% on a reported basis and up 8.4% on a constant currency revenue, organic* basis, compared to Q4 2020 Q4 2021 GAAP EPS increased 32% year-over-year to $0.36, compared to $0.27 in Q4 2020 Q4 2021 non-GAAP EPS* increased 31% year-
Read more →MMSIMerit Medical Systems to Announce Fourth Quarter and Year End 2021 Results on February 24, 2022
SOUTH JORDAN, Utah, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
Read more →MMSIPR/Media Inquiries: Teresa Johnson Merit Medical Investor Inquiries: Mike Piccinino, CFA, IRC Westwicke - ICR +1-801-208-4295 +1-443-213-0509 tjohnson@merit.com mike.piccinino@westwicke.com
Contacts: PR/Media Inquiries: Teresa Johnson Merit Medical Investor Inquiries: Mike Piccinino, CFA, IRC Westwicke - ICR +1-801-208-4295 +1-443-213-0509 tjohnson@merit.com mike.piccinino@westwicke.com MERIT MEDICAL ANNOUNCES AGREEMENT IN PRINCIPLE TO SETTLE CLAS
Read more →MMSIMerit Medical Announces Agreement in Principle to Settle Class Action Litigation
SOUTH JORDAN, Utah, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, cri
Read more →MMSIMerit Medical Reports Results For Quarter Ended September 30, 2021
Q3 2021 reported revenue of $267.0 million, up 9.4% compared to Q3 2020 Q3 2021 constant currency revenue, organic* up 8.8% compared to Q3 2020 Q3 2021 GAAP EPS of $0.21, compared to GAAP loss per share of ($0.05) in Q3 2020 Q3 2021 non-GAAP EPS* of $0.52, compared to $0.42 in
Read more →MMSIMerit Medical Systems to Announce Third Quarter Results on October 28, 2021
SOUTH JORDAN, Utah, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
Read more →MMSIMerit Medical Announces Positive Results in First-in-Human Study of WRAPSODY™ Cell-Impermeable Endoprosthesis
Prospective, observational study published in CardioVascular and Interventional Radiology1 reports 100% target lesion primary patency (“TLPP”) rate without reintervention through 30 days, with a 12-month TLPP rate of 84.6% and a 12-month access circuit primary patency (“ACPP”) ra
Read more →MMSIMerit Medical Launches One-Vac™ Evacuated Drainage Bottle for Percutaneous Fluid Collection and Discard
SOUTH JORDAN, Utah, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, o
Read more →MMSIMerit Medical Reports Results for Quarter Ended June 30, 2021
Q2 2021 reported revenue of $280.3 million, up 28.4% compared to Q2 2020 Q2 2021 constant currency revenue, organic* up 25.5% compared to Q2 2020 Q2 2021 GAAP EPS of $0.09, compared to GAAP loss per share of ($0.34) in Q2 2020 Q2 2021 non-GAAP EPS* of $0.62, compared to $0.31
Read more →MMSIMerit Medical Systems to Announce Second Quarter Results on July 29, 2021
SOUTH JORDAN, Utah, July 09, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
Read more →MMSIMerit Medical Reports Results for Quarter Ended March 31, 2021
Q1 2021 reported revenue of $248.9 million, up 2.2% compared to Q1 2020 Q1 2021 constant currency revenue, organic* up 0.6% compared to Q1 2020 Q1 2021 GAAP EPS of $0.19, compared to GAAP loss per share of ($0.06) in Q1 2020 Q1 2021 non-GAAP EPS* of $0.52, compared to $0.38 in
Read more →MMSIMerit Medical Systems to Announce First Quarter Results on April 29, 2021
SOUTH JORDAN, Utah, April 09, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
Read more →MMSIMerit Medical to Present at 20th Annual Needham Healthcare Conference
SOUTH JORDAN, Utah, April 08, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, o
Read more →MMSIMerit Medical Reports Results For Fourth Quarter and Year Ended December 31, 2020, Issues FY 2021 Guidance
Q4 2020 reported revenue of $258.0 million, approximately equal to Q4 2019 revenue Q4 2020 core revenue on a constant currency basis* down (1.0)% compared to Q4 2019 Q4 2020 GAAP EPS of $0.27, compared to GAAP loss per share of ($0.08) in Q4 2019 Q4 2020 non-GAAP EPS* of $0.54
Read more →MMSIMerit Medical Systems to Announce Fourth Quarter and Year End 2020 Results on February 24, 2021
SOUTH JORDAN, Utah, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
Read more →MMSIMerit Medical to Present at 2021 SVB Leerink Global Healthcare Conference
SOUTH JORDAN, Utah, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, on
Read more →MMSIMerit Medical to Participate in Two Upcoming Investor Conferences
SOUTH JORDAN, Utah, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, on
Read more →MMSIPR/Media Inquiries: Teresa Johnson Merit Medical Investor Inquiries: Mike Piccinino, CFA, IRC Westwicke - ICR +1-801-208-4295 +1-443-213-0509 tjohnson@merit.com Mike.piccinino@westwicke.com FOR IMMEDIATE RELEAS
Contacts: PR/Media Inquiries: Teresa Johnson Merit Medical Investor Inquiries: Mike Piccinino, CFA, IRC Westwicke - ICR +1-801-208-4295 +1-443-213-0509 tjohnson@merit.com Mike.piccinino@westwicke.com MERIT MEDICAL TO PRESENT "FOUNDATIONS FOR GROWTH" PROGRAM and
Read more →MMSIMerit Medical to Present “Foundations for Growth” Program and Financial Targets for 2020 to 2023
SOUTH JORDAN, Utah, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, on
Read more →MMSIMerit Medical Reports Results for Third Quarter; Issues Updated 2020 Guidance
Q3 2020 worldwide revenue of $244.0 million, up 0.4% as reported compared to Q3 2019 Q3 2020 core revenue on a constant currency basis* down (0.1)% compared to Q3 2019 Q3 2020 GAAP loss per share of $(0.05), compared to $(0.06) in Q3 2019 Q3 2020 non-GAAP EPS* of $0.42, compar
Read more →MMSIMerit Medical Systems Finalizes Resolution with the Government
SOUTH JORDAN, Utah, Oct. 13, 2020 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
Read more →MMSIMerit Medical Systems to Announce Third Quarter Results on October 28, 2020 and Host “Foundations for Growth” Investor Call on November 10, 2020
SOUTH JORDAN, Utah, Oct. 09, 2020 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will rel
Read more →MMSIMerit Medical to Participate at Four Conferences in September
SOUTH JORDAN, Utah, Sept. 02, 2020 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
Read more →MMSIMerit Medical to Participate at Canaccord Genuity and Needham Conferences
SOUTH JORDAN, Utah, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
Read more →MMSIJudy Wagner Patrick McCarty Corporate Communications Investor Relations +1-801-208-4793 +1-801-208-4581 jwagner@merit.com patrick.mccarty@merit.com FOR IMMEDIATE RELEASE MERIT MEDICAL REPORTS RESULTS FOR QUARTE
Contacts: Judy Wagner Patrick McCarty Corporate Communications Investor Relations +1-801-208-4793 +1-801-208-4581 jwagner@merit.com patrick.mccarty@merit.com MERIT MEDICAL REPORTS RESULTS FOR QUARTER ENDED JUNE 30, 2020 * Core revenue on a constant currenc
Read more →MMSIMerit Medical Reports Results for Quarter Ended June 30, 2020
Q2 2020 worldwide revenue of $218.4 million, down (14.5)% as reported compared to Q2 2019 Q2 2020 core revenue on a constant currency basis* down (13.6)% compared to Q2 2019 Q2 2020 GAAP loss per share was $(0.34), compared to GAAP EPS of $0.12 in Q2 2019 Q2 2020 non-GAAP EPS*
Read more →MMSIMerit Medical Systems to Announce Second Quarter Results on July 29, 2020
SOUTH JORDAN, Utah, July 17, 2020 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology, oncology, critical care and endoscopy announced today that it will rele
Read more →MMSIMerit Medical Announces Agreement in Principle with Department of Justice
SOUTH JORDAN, Utah, July 15, 2020 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
Read more →MMSIStatements contained in this release which are not purely historical, including, without limitation, statements regarding the anticipated resolution of an ongoing investigation bei
Date: July 15, 2020 Contact: Fred P. Lampropoulos, Chairman and Chief Executive Officer Phone: (801) 253-1600 e-mail: Fred@merit.com MERIT MEDICAL ANNOUNCES AGREEMENT IN PRINCIPLE WITH DEPARTMENT OF JUSTICE SOUTH JORDAN, Utah, July 15, 2020 (GLOBE NEWSWIRE) -- Merit Medical Sy
Read more →MMSIMerit Medical Announces Agreement With Starboard
Nominates Three Medical Device Industry Veterans – Lonny Carpenter, David Floyd and James Hogan – for Election to the Board of Directors Announces Formation of Operating Committee to Review Margin Improvement Initiatives and Establish Targets SOUTH JORDAN, Utah, May 26, 2020 (G
Read more →MMSIMerit Medical Receives CE Mark for Wrapsody™ Endovascular Stent Graft System
SOUTH JORDAN, Utah, May 26, 2020 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, c
Read more →MMSIStatements contained in this release which are not purely historical, including, without limitation, statements regarding Merit's forecasted plans, net sales, net income (GAAP and
Date: April 23, 2020 Contact: Anne-Marie Wright, Vice President, Corporate Communications Phone: (801) 208 4167 e-mail: awright@merit.com Fax: (801) 253 1688 MERIT MEDICAL REPORTS EARNINGS FOR QUARTER ENDED MARCH 31, 2020, WITHDRAWS FY 2020 GUIDANCE * Core revenue on a consta
Read more →MMSIMerit Medical Reports Earnings for Quarter Ended March 31, 2020, Withdraws FY 2020 Guidance
Q1 2020 worldwide revenue of $243.5 million, up 2.2% as reported over Q1 2019 Q1 2020 core revenue on a constant currency basis* up 3.0% over Q1 2019 Q1 2020 GAAP loss per share was $(0.06), compared to GAAP EPS of $0.11 in Q1 2019 Q1 2020 non-GAAP EPS* was $0.38, compared to
Read more →MMSIMERIT MEDICAL SYSTEMS DESIGNS AND PRODUCES SAMPLE COLLECTION AND TRANSPORT KIT
SOUTH JORDAN, Utah, April 20, 2020 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that it has commenced production of a sa
Read more →MMSIMerit Medical Systems to Announce First Quarter Results on April 23, 2020
SOUTH JORDAN, Utah, April 14, 2020 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that it will release its financial resul
Read more →MMSIMERIT MEDICAL RECEIVES TWO ADDITIONAL FDA BREAKTHROUGH DEVICE DESIGNATIONS
SOUTH JORDAN, Utah, April 06, 2020 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
Read more →MMSIStatements contained in this release which are not purely historical, including, without limitation, statements regarding Merit's forecasted plans and other financial information,
Date: April 3, 2020 Contact: Anne-Marie Wright, Vice President, Corporate Communications Phone: (801) 208 4167 e-mail: awright@merit.com Fax: (801) 253 1688 MERIT MEDICAL PROVIDES HISTORICAL REVENUES IN REVISED PRESENTATION FORMAT *Core revenue is a non-GAAP financial measure.
Read more →MMSIMERIT MEDICAL PROVIDES HISTORICAL REVENUES IN REVISED PRESENTATION FORMAT
*Core revenue is a non-GAAP financial measure. A reconciliation of core revenue to GAAP revenue is included under the heading “Non-GAAP Financial Measures” below. SOUTH JORDAN, Utah, April 03, 2020 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufac
Read more →MMSIMerit Medical Response to Earthquake in Salt Lake City
SOUTH JORDAN, Utah, March 18, 2020 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
Read more →MMSIMerit Medical to Present at Oppenheimer and BTIG Conferences
SOUTH JORDAN, Utah, March 02, 2020 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
Read more →MMSIMerit Medical Reports Earnings for Fourth Quarter and Year Ended December 31, 2019, Gives FY 2020 Guidance
Q4 2019 worldwide revenue of $257.9 million, up 10.6% as reported over Q4 2018 Q4 2019 core revenue on a comparable, constant currency basis* up 8.5% over Q4 2018 Q4 2019 GAAP loss per share was $(0.08), compared to GAAP EPS of $0.16 in Q4 2018 Q4 2019 non-GAAP EPS* was $0.40,
Read more →MMSIMerit Medical Systems Announces Four Regulatory Approvals
SOUTH JORDAN, Utah, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that regulatory clearances have been issu
Read more →MMSIMerit Medical to Present at SVB Leerink Conference
SOUTH JORDAN, Utah, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
Read more →MMSIMerit Medical Systems to Announce Fourth Quarter and Year End 2019 Results on February 24, 2020
SOUTH JORDAN, Utah, Feb. 13, 2020 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that it will release its financial result
Read more →MMSIMERIT MEDICAL DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Merit Medical Systems, Inc. To Contact The Firm
NEW YORK, Jan. 29, 2020 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Merit Medical Systems, Inc. (“Merit Medical” or the “Company”) (NASDAQ:MMSI) of the February 3, 2020 deadline to seek the role of lead plaintiff in a fed
Read more →MMSIMerit Medical Issues Statement Regarding Director Nominations From Starboard
SOUTH JORDAN, Utah, Jan. 27, 2020 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
Read more →MMSIMERIT MEDICAL SYSTEMS, INC. INVESTOR REMINDER: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the District of Utah
NEW YORK, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been filed in the United States District Court for the District of Utah on behalf of Merit Medical Systems, Inc. (“Merit” or the “Co
Read more →MMSIMERIT MEDICAL SYSTEMS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the District of Utah
NEW YORK, Dec. 11, 2019 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been filed in the United States District Court for the District of Utah on behalf of Merit Medical Systems, Inc. (“Merit” or the “Co
Read more →MMSIMERIT LOSS ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Merit Medical Systems, Inc. – MMSI
NEW YORK, Dec. 07, 2019 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Merit Medical Systems, Inc. (NASDAQ: MMSI) between February 26, 2019 and October 30, 2019, in
Read more →MMSIMerit Medical Receives FDA Breakthrough Device Designation for WRAPSODY™ Endovascular Stent Graft System
SOUTH JORDAN, Utah, Nov. 21, 2019 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
Read more →MMSIStatements contained in this release which are not purely historical, including, without limitation, statements regarding the development, introduction or commercialization of new
Date:November 21, 2019 Contact:Anne-Marie Wright, Vice President, Corporate Communications Phone:(801) 208-4167 e-mail: awright@merit.com Fax: (801) 253-1688 MERIT MEDICAL RECEIVES FDA BREAKTHROUGH DEVICE DESIGNATION FOR WRAPSODY ENDOVASCULAR STENT GRAFT SYSTEM SOUTH JORDAN
Read more →MMSIMerit Medical to Participate at Three Upcoming Conferences
SOUTH JORDAN, Utah, Nov. 06, 2019 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
Read more →MMSIMerit Medical Reports Earnings for Third Quarter of 2019
Q3 2019 worldwide revenue of $243.0 million, up 9.6% as reported over Q3 2018 Q3 2019 core revenue on a comparable, constant currency basis* up 4.3% over Q3 2018 Q3 2019 GAAP loss per share was $(0.06), compared to GAAP EPS of $0.30 in Q3 2018 Q3 2019 non-GAAP EPS* was $0.28,
Read more →MMSIMerit Medical Systems to Announce Third Quarter Results on October 30, 2019
SOUTH JORDAN, Utah, Oct. 18, 2019 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that it will release its financial result
Read more →MMSIMerit Medical to Present at Three Conferences in September
SOUTH JORDAN, Utah, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
Read more →MMSIMerit Medical Announces Appointment of Lynne N. Ward to Its Board of Directors
SOUTH JORDAN, Utah, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
Read more →MMSIMerit Medical Reports Earnings For Second Quarter of 2019
Q2 2019 worldwide revenue of $255.5 million, up 13.7% as reported over Q2 2018 Q2 2019 core revenue on a comparable, constant currency basis* up 9.6% over Q2 2018 Q2 2019 GAAP EPS was $0.12, compared to $0.21 in Q2 2018 Q2 2019 non-GAAP EPS* was $0.42, compared to $0.43 in Q2
Read more →MMSIMerit Medical Systems to Announce Second Quarter Results on July 25, 2019
SOUTH JORDAN, Utah, July 09, 2019 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that it will release its financial result
Read more →MMSIMerit Medical Acquires Brightwater Medical, Inc.
SOUTH JORDAN, Utah, June 17, 2019 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
Read more →MMSIMerit Medical Awarded Interventional Fluid Management Agreement With Premier
SOUTH JORDAN, Utah, June 11, 2019 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
Read more →MMSIMerit Medical to Present at Raymond James Conference
SOUTH JORDAN, Utah, June 10, 2019 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
Read more →MMSIMerit Medical to Present at Three Conferences in May
SOUTH JORDAN, Utah, April 30, 2019 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
Read more →MMSIMerit Medical Reports Earnings for Quarter Ended March 31, 2019
Q1 2019 worldwide revenue of $238.3 million, up 17.4% as reported over Q1 2018 Q1 2019 core revenue on a comparable, constant currency basis* up 10.0% over Q1 2018 Q1 2019 GAAP EPS was $0.11, compared to $0.10 in Q1 2018 Q1 2019 non-GAAP EPS* was $0.37, compared to $0.31 in Q1
Read more →MMSIMerit Medical Systems to Announce First Quarter Results on April 23, 2019
SOUTH JORDAN, Utah, April 10, 2019 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
Read more →MMSIMerit Medical to Present at Needham Healthcare Conference
SOUTH JORDAN, Utah, March 28, 2019 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
Read more →MMSIMerit Medical Reports Earnings for Fourth Quarter and Year Ended December 31, 2018, Gives 2019 and 2020 Guidance
Q4 2018 worldwide revenue of $233.2 million, up 22.2% as reported over Q4 2017 Q4 2018 core revenue on a comparable, constant currency basis* up 13.1% over Q4 2017 Q4 2018 GAAP EPS was $0.16, compared to $0.13 in Q4 2017 Q4 2018 non-GAAP EPS* was $0.48, compared to $0.33 in Q4
Read more →MMSIMerit Medical to Participate at Six Upcoming Conferences
SOUTH JORDAN, Utah, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
Read more →MMSIMerit Medical Systems to Announce Fourth Quarter and Year End Results and 2019 Guidance on February 26, 2019
SOUTH JORDAN, Utah, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that it will release its financial result
Read more →MMSIMerit Medical to Present at Needham Growth Conference
SOUTH JORDAN, Utah, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
Read more →MMSIMerit Medical Announces Appointment of Two New Directors
SOUTH JORDAN, Utah, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
Read more →MMSIMerit Medical Acquires Assets of Vascular Insights, LLC
SOUTH JORDAN, Utah, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
Read more →MMSIMerit Medical Ireland Wins Medtech Company of the Year Award 2018
SOUTH JORDAN, Utah, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
Read more →MMSIMerit Medical Closes Cianna Medical, Inc. Deal
SOUTH JORDAN, Utah, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
Read more →MMSIMerit Medical to Present at Four Conferences in November
SOUTH JORDAN, Utah, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
Read more →MMSIMerit Medical Reports Earnings for Third Quarter of 2018
Q3 2018 worldwide revenue of $221.7 million ($223.1 million on a comparable, constant currency* basis), up 23.6% as reported (up 24.4% on a comparable, constant currency* basis) over Q3 2017 Q3 2018 core revenue* up 14.6% over Q3 2017 core revenue* (core revenue* up 15.4% on a c
Read more →MMSIMerit Medical Systems to Announce Third Quarter Results on October 25, 2018
SOUTH JORDAN, Utah, Oct. 08, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
Read more →MMSIMerit Medical Signs Agreement to Acquire Cianna Medical, Inc.
SOUTH JORDAN, Utah, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
Read more →MMSIMerit Medical to Present at Three Upcoming Conferences
SOUTH JORDAN, Utah, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
Read more →MMSIMerit Medical to Present at Two Conferences in August
SOUTH JORDAN, Utah, July 31, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, c
Read more →MMSIMerit Medical Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters’ Over-Allotment Option
SOUTH JORDAN, Utah, July 30, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI) (“Merit”), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, o
Read more →MMSIresults or outcomes to be materially different from those expressed or implied by the forward-looking statements.
Contact: Anne-Marie Wright, Vice President, Corporate Communications Phone: (801) 208-4167 e-mail: awright@merit.com Fax: (801) 253-1688 MERIT MEDICAL ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK SOUTH JORDAN, UTAH Merit Medical Systems, Inc. (NASDAQ: MMSI) ( Merit ),
Read more →MMSIMerit Medical Announces Pricing of Public Offering of Common Stock
SOUTH JORDAN, Utah, July 25, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI) (“Merit”), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, o
Read more →MMSIMerit Medical Announces Commencement of Public Offering of Common Stock
SOUTH JORDAN, Utah, July 24, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI) (“Merit”), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, o
Read more →MMSIMerit Medical Reports Record Revenues for Second Quarter of 2018; Merit Adjusts 2018 Guidance
Q2 2018 worldwide revenue of $224.8 million ($221.2 million on a comparable, constant currency* basis), up 20.5% as reported (up 18.6% on a comparable, constant currency* basis) over Q2 2017 Q2 2018 core revenue* up 11.7% over Q2 2017 core revenue* (core revenue* up 9.8% on a co
Read more →MMSIMerit Medical Systems to Announce Second Quarter Results on July 23, 2018
SOUTH JORDAN, Utah, July 16, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, c
Read more →MMSIMerit Medical Announces Leadership Change and Appointment of Interim CFO
SOUTH JORDAN, Utah, May 31, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, cr
Read more →MMSIMerit Medical Enters Strategic Alliance and Worldwide Distribution with NinePoint Medical
SOUTH JORDAN, Utah, May 02, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, cr
Read more →MMSIMerit Medical Reports Record Revenues for First Quarter of 2018
Q1 2018 worldwide revenue of $203.0 million ($197.9 million on a comparable, constant currency* basis), up 18.7% as reported (up 15.7% on a comparable, constant currency* basis) over Q1 2017 Q1 2018 core revenue* up 10.1% over Q1 2017 core revenue* (core revenue* up 7.1% on a co
Read more →MMSIMerit Medical Systems to Announce First Quarter Results on April 25, 2018
SOUTH JORDAN, Utah, April 11, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
Read more →MMSIMerit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2017; Merit Meets Range of 2017 Guidance; Gives 2018 Guidance
Q4 2017 worldwide revenue of $190.9 million ($188.2 million on a comparable, constant currency* basis), up 21.0% as reported (up 19.3% on a comparable, constant currency* basis) over Q4 2016 FY 2017 worldwide revenue of $727.9 million ($727.3 million on a comparable, constant cu
Read more →MMSIMerit Medical to Participate at Six Conferences
Raymond James – March 7 Oppenheimer – March 21 SOUTH JORDAN, Utah, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic proce
Read more →MMSIMerit Medical Closes Deal With BD for Purchase of Divestment Assets
SOUTH JORDAN, Utah, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, c
Read more →MMSIMerit Medical Systems to Announce Fourth Quarter and Year End Results on February 28, 2018
SOUTH JORDAN, Utah, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, onc
Read more →MMSIThe assets to be acquired are soft tissue core needle biopsy products currently sold by BD under the trade names of Achieve Programmable Automatic Biopsy System, Temno Biopsy Syste
Date: November 16, 2017 Contact: Anne-Marie Wright, Vice President, Corporate Communications Phone: (801) 208-4167 e-mail: awright@merit.com Fax: (801) 253-1688 MERIT MEDICAL SIGNS PURCHASE AGREEMENT WITH BD FOR DIVESTMENT ASSETS SOUTH JORDAN, UTAH Merit Medical Systems, Inc.
Read more →MMSIMerit Medical Signs Purchase Agreement with BD for Divestment Assets
SOUTH JORDAN, Utah, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, c
Read more →MMSIMerit Medical to Participate at Three Conferences
Canaccord Genuity – November 9 Jefferies – November 16 Piper Jaffray – November 29 SOUTH JORDAN, Utah, Oct. 30, 2017 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiolog
Read more →MMSIMerit Medical Reports Results for Third Quarter 2017
Q3 2017 worldwide revenue of $179.3 million ($178.3 million on a comparable, constant currency* basis), up 14.2% as reported (up 13.6% on a comparable, constant currency* basis) over Q3 2016 YTD 2017 worldwide revenue of $537.0 million ($539.1 million on a comparable, constant c
Read more →MMSIMerit Medical Systems to Announce Third Quarter Results on October 25, 2017
SOUTH JORDAN, Utah, Oct. 12, 2017 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that it will release its financial results
Read more →MMSIMerit Medical to Participate at Five Conferences
Wells Fargo – September 6 Credit Suisse – September 14 Cantor Fitzgerald – September 25 Barrington – September 27 Sidoti – September 28 SOUTH JORDAN, Utah, Aug. 29, 2017 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of pro
Read more →MMSIMerit Medical Reports Record Revenue and Non-GAAP Net Income* for Second Quarter 2017, Raises 2017 Guidance and Gives Preliminary 2018-2019 Guidance
Q2 2017 worldwide revenue of $186.5 million ($188.7 million on a comparable, constant currency* basis), up 23.5% as reported (up 24.9% on a comparable, constant currency* basis) over Q2 2016 YTD 2017 worldwide revenue of $357.6 million ($361.0 million on a comparable, constant c
Read more →MMSIMerit Medical Systems to Announce Second Quarter Results on July 26, 2017
SOUTH JORDAN, Utah, July 10, 2017 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that it will release its financial results
Read more →MMSIMerit Medical’s Embosphere Microspheres Receive FDA 513(f)(2) (de novo) Classification for Prostatic Artery Embolization Indication
SOUTH JORDAN, Utah, June 22, 2017 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology and endoscop
Read more →MMSIMerit Medical Announces Appointment of New Director
SOUTH JORDAN, Utah, May 26, 2017 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology and e
Read more →MMSIMerit Medical Reports Results for First Quarter of 2017
Q1 worldwide revenue of $171.1 million ($172.3 million on a comparable, constant currency* basis), up 23.9% as reported (up 24.8% on a comparable, constant currency* basis) over Q1 2016 Q1 2017 core revenue* up 11.7% over Q1 2016 core revenue* (core revenue* up 12.6% on a compar
Read more →MMSIMerit Medical Systems to Announce First Quarter Results on April 27, 2017
SOUTH JORDAN, Utah, April 04, 2017 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that it will release its financial result
Read more →MMSIMerit Medical to Participate at Needham Healthcare Conference
SOUTH JORDAN, Utah, March 30, 2017 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will present at the 16th Annual N
Read more →MMSIMerit Medical Announces Closing of Public Offering of Common Stock
SOUTH JORDAN, Utah, March 29, 2017 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI) (“Merit”), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology a
Read more →MMSIMerit Medical Announces Full Exercise of Option to Purchase Additional Common Stock
SOUTH JORDAN, Utah, March 27, 2017 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI) (“Merit”), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology a
Read more →MMSIDate: March [ ], 2017 Contact: Anne-Marie Wright, Vice President, Corporate Communications Phone: (801) 208-4167 e-mail: awright@merit.com Fax: (801) 253-1688 MERIT MEDICAL ANNOUNCES COMMENCEMENT OF
Date: March [ ], 2017 Contact: Anne-Marie Wright, Vice President, Corporate Communications Phone: (801) 208-4167 e-mail: awright@merit.com Fax: (801) 253-1688 MERIT MEDICAL ANNOUNCES COMMENCEMENT OF PUBLIC OFFERING OF COMMON STOCK SOUTH JORDAN, UTAH Merit Medical Systems, In
Read more →MMSIMerit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2016
Q4 worldwide revenue of $157.7 million ($159.0 million on a comparable, constant currency* basis), up 14.0% as reported (up 14.9% on a comparable, constant currency* basis) over Q4 2015 FY16 worldwide revenue of $603.8 million ($608.8 million on a comparable, constant currency*
Read more →MMSIMerit Medical to Participate at BTIG and Barclays Conferences
SOUTH JORDAN, Utah, Feb. 16, 2017 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will present at two investor confe
Read more →MMSIMerit Medical to Participate at RBC Conference
SOUTH JORDAN, Utah, Feb. 07, 2017 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology and endoscop
Read more →MMSIMerit Medical Acquires Products From Argon Medical Devices and Catheter Connections, Inc.
SOUTH JORDAN, Utah, Feb. 06, 2017 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that it has acquired certain products from
Read more →MMSIMerit Medical to Present at J.P. Morgan Healthcare Conference
SOUTH JORDAN, Utah, Dec. 19, 2016 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology and endoscop
Read more →MMSIMerit Medical Receives 510(k) Clearance for the SwiftNINJA™ Steerable Microcatheter
SOUTH JORDAN, Utah, Nov. 07, 2016 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology and endoscop
Read more →MMSIMerit Medical Reports Sales Up 15.3% for the Quarter Ended September 30, 2016
Q3 revenue of $157.0 million ($158.1 million on a comparable, constant currency basis), up 15.3% as reported (up 16.1% on a comparable, constant currency basis) over Q3 2015 Q3 core revenue up 8.9% over Q3 2015 Q3 GAAP EPS was $0.02; Q3 non-GAAP EPS was $0.26 Q3 2016 GAAP gros
Read more →MMSIMerit Medical Completes Enrollment in EVOLVE Study
SOUTH JORDAN, Utah, Oct. 19, 2016 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that it has completed enrollment in its EV
Read more →MMSIMerit Medical Launches Super HeRO™ and HeRO™ Ally Products
SOUTH JORDAN, Utah, Oct. 18, 2016 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today the launch of the proprietary Super HeRO™
Read more →MMSIMerit Medical Systems to Announce Third Quarter Results on October 26, 2016
SOUTH JORDAN, Utah, Oct. 04, 2016 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that it will release its financial results
Read more →MMSIMerit Medical Receives 510(K) Clearance for the Elation Pulmonary Dilation Balloon
SOUTH JORDAN, Utah, Sept. 07, 2016 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology and endosco
Read more →MMSIMerit Medical to Present at Five Conferences
Wells Fargo – September 7 Barrington - September 8 CL King – September 12 Morgan Stanley – September 13 Credit Suisse – September 14 SOUTH JORDAN, Utah, Aug. 25, 2016 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of propri
Read more →MMSIMerit Medical to Present at Two Conferences
Canaccord Genuity – August 11 SOUTH JORDAN, Utah, Aug. 01, 2016 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in car
Read more →MMSIMerit Medical Reports Sales Up 9.4% for the Quarter Ended June 30, 2016
Q2 revenue of $151.1 million ($151.7 million in constant currency), up 9.4% as reported, up 9.9% on a comparable, constant currency basis, over Q2 2015 YTD revenue of $289.1 million ($291.7 million in constant currency), up 8.0% as reported, up 9.0% on a comparable, constant cur
Read more →MMSIMerit Medical Systems to Announce Second Quarter Results on July 27, 2016
SOUTH JORDAN, Utah, July 14, 2016 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that the Company will release its financia
Read more →MMSIMerit Medical Acquires DFINE, Inc.
SOUTH JORDAN, Utah, July 06, 2016 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it has acquired DFINE, Inc. headquart
Read more →MMSIMerit Medical to Present at UBS Global Healthcare Conference
SOUTH JORDAN, Utah, May 12, 2016 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate at the UBS Global
Read more →MMSIMerit Medical Appointed Global Distributor for Micro Guide Wire
SOUTH JORDAN, Utah, May 10, 2016 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it has signed a distribution deal with
Read more →MMSIMerit Medical Reports Sales Up 6.6% for the Quarter Ended March 31, 2016
Q1 revenue of $138.1 million ($140.0 million in constant currency), up 6.6% as reported, up 8.0% on a comparable, constant currency basis Q1 non-GAAP EPS was $0.19; GAAP EPS was $0.10 Q1 2016 non-GAAP gross margin was 45.9%, compared to 44.9% in Q1 2015; Q1 2016 GAAP gross marg
Read more →MMSIMerit Medical Systems to Announce First Quarter Results on April 28, 2016
SOUTH JORDAN, Utah, April 04, 2016 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that the Company will release its financi
Read more →MMSIMerit Medical Announces 510(k) Clearance for Corvocet™ Biopsy System
SOUTH JORDAN, Utah, March 28, 2016 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it received notification of substant
Read more →MMSIMerit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2015
Q4 worldwide revenue of $138.4 million ($141.0 million constant currency), up 4.2% as reported, up 6.2% on a comparable, constant currency basis Q4 non-GAAP diluted EPS were $0.24; GAAP EPS were $0.14 FY15 revenue of $542.1 million ($553.4 million in constant currency), up 6.4%
Read more →MMSIMerit Medical to Present at Four Conferences
RBC Capital Markets – February 24 Credit Suisse – March 16 SOUTH JORDAN, Utah, Feb. 10, 2016 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscop
Read more →MMSIMerit Medical Acquires the HeRO Graft From CryoLife, Inc.
SOUTH JORDAN, Utah, Feb. 04, 2016 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, to
Read more →MMSIMerit Medical Systems to Announce Fourth Quarter and Year End Results on February 22, 2016
SOUTH JORDAN, Utah, Feb. 04, 2016 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that the Company will release its financia
Read more →MMSIMerit Medical to Present at Three Conferences
Barclays – November 16 Canaccord Genuity – November 19 Piper Jaffray – December 1 SOUTH JORDAN, Utah, Nov. 10, 2015 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology
Read more →MMSIMerit Medical Receives Four New Regulatory Approvals
CE Marking for Centros® Dialysis Catheter CE Marking for HepaSphere™ with Irinotecan Indication 510(k) Clearance for Prelude SNAP™ Splittable Hydrophilic Sheath 510(k) Clearance for Elation® Wireguided Balloon Dilation Catheter with Biliary Indication SOUTH JORDAN, Utah, Nov.
Read more →MMSIMerit Medical Names New Chief Financial Officer
SOUTH JORDAN, Utah, Nov. 06, 2015 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, to
Read more →MMSIMerit Medical Announces Results for the Quarter Ended September 30, 2015
Revenues Up 6% for 3Q and 7% YTD Revenues on Constant Currency Basis Up 8% for 3Q and 9% YTD Endotek Sales Up 11% for 3Q and 16% YTD Centros® and CentrosFLO® Catheters Receive CE Mark Steerable Microcatheter Now Available in Europe SOUTH JORDAN, Utah, Oct. 22, 2015 (GLOBE NE
Read more →MMSIMerit Medical Systems, Inc. and Sumitomo Bakelite Co., Ltd. Sign Distribution Deal for Steerable Microcatheter
SOUTH JORDAN, Utah, Oct. 06, 2015 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, an
Read more →MMSIMerit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the Third Quarter Ended September 30, 2015
SOUTH JORDAN, Utah, Oct. 2, 2015 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, ann
Read more →MMSIMerit Medical to Present at Four Conferences in September
Barrington Research – September 2 CL King – September 10 Wells Fargo – September 10 Morgan Stanley – September 17 SOUTH JORDAN, Utah, Aug. 26, 2015 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable dev
Read more →MMSIMerit Medical to Present at Canaccord Genuity Growth Conference
SOUTH JORDAN, Utah, Aug. 05, 2015 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will present at the 35th Annual Ca
Read more →MMSIMerit Medical Receives FDA 510(k) Clearance Expanding Indication for QuadraSphere Microspheres to Include Hepatoma
SOUTH JORDAN, Utah, Aug. 04, 2015 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, to
Read more →MMSIMerit Medical Reports Record Revenues for the Quarter and Six Months Ended June 30, 2015
Non-GAAP Net Income Up 70% for 2Q Revenues Up 7.2% for 2Q Revenues Up 10% for 2Q and YTD When Adjusted for Constant Currency Non-GAAP Gross Margin Up 80 Basis Points Over 2Q 2014 and Up 124 Basis Points Over 1Q 2015 Expense Discipline Continues Tijuana, Mexico Facility Comme
Read more →MMSIMerit Medical Announces Appointment of New Independent Director
SOUTH JORDAN, Utah, July 20, 2015 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, an
Read more →MMSIMerit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the Second Quarter Ended June 30, 2015
SOUTH JORDAN, Utah, July 6, 2015 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, ann
Read more →MMSIMerit Medical Reports Sales Up 9% for the Quarter Ended March 31, 2015
GAAP Net Income Up 83% Non-GAAP Net Income Up 47% Merit's PreludeSnap Splittable Sheath Introducer Receives 510(k) Clearance Cash Flow From Operations Improved To $19.3 Million From $8.0 Million SOUTH JORDAN, Utah, April 23, 2015 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc
Read more →MMSIMerit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the First Quarter Ended March 31, 2015
SOUTH JORDAN, Utah, April 16, 2015 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, a
Read more →MMSIMerit Medical to Present at Sidoti & Company's Small-Cap Equity Conference
SOUTH JORDAN, Utah, March 10, 2015 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate at Sidoti & Comp
Read more →MMSIWest Merit Parkway South Jordan, UT 84095 Telephone: 801-253-1600 Fax: 801-253-1688 PRESS RELEASE ____________________________________________________________________________ FOR IMMEDIATE RELEASE Date
1600 West Merit Parkway South Jordan, UT 84095 Telephone: 801-253-1600 Fax: 801-253-1688 ____________________________________________________________________________ Date: March 5, 2015 Contact: Anne-Marie Wright, Vice President, Corporate Communications Phone: (801) 208-4167
Read more →MMSIMerit Medical Details Three-Year Plan to Accelerate Profitable Growth
Company Holds First Investor Day Projects Revenues to Approach $635 Million in FY2017 Expects Improvement in Non-GAAP Net Income of over 50% by 2017 Foresees Improvement in Non-GAAP Gross Margin of up to 240 Basis Points Anticipates Improvement in GAAP Net Income of over 85%
Read more →MMSIMerit Medical Reports Record Revenues and Income for the Quarter and Year Ended December 31, 2014
SOUTH JORDAN, Utah, Feb. 24, 2015 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced record revenues of $132.8 million for the
Read more →MMSIMerit Medical Systems Announces Dates for Earnings Release and Investor Day
Fourth Quarter and Year End Results Scheduled for Release on February 24, 2015 Investor Day Scheduled for March 5, 2015 SOUTH JORDAN, Utah, Jan. 16, 2015 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable
Read more →MMSIMerit Medical Announces Multiple Regulatory Approvals
SOUTH JORDAN, Utah, Dec. 10, 2014 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it has received 501(k) clearance for
Read more →MMSIMerit Medical to Participate at Piper Jaffray Healthcare Conference
SOUTH JORDAN, Utah, Nov. 24, 2014 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate at the 26th Annua
Read more →MMSIMerit Medical to Present at Stephens and Canaccord Genuity Conferences This Month
SOUTH JORDAN, Utah, Nov. 7, 2014 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate in two investor co
Read more →MMSIMerit Medical and Bard Access Systems, Inc. Settle Dispute
SOUTH JORDAN, Utah, Oct. 30, 2014 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, to
Read more →MMSIMerit Medical Announces Results for the Quarter Ended September 30, 2014
Revenues Up 12% for Third Quarter Gross Margin Up 140 Basis Points Sequentially from Second Quarter Income from Operations Improves to 9.4% for Third Quarter Third Quarter SG&A Expenses Down 180 Basis Points Sequentially Non-GAAP EPS $0.25 for Third Quarter Relocation to Pea
Read more →MMSIMerit Medical Unveils New ThinkRadial(TM) Website and Educational Initiative
SOUTH JORDAN, Utah, Oct. 13, 2014 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, to
Read more →MMSIMerit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the Third Quarter Ended September 30, 2014
SOUTH JORDAN, Utah, Oct. 2, 2014 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, ann
Read more →MMSIMerit Medical to Present at CL King Conference
SOUTH JORDAN, Utah, Sept. 2, 2014 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate in CL King's 12th
Read more →MMSIMerit Medical Reports Record Revenues for the Quarter and Six Months Ended June 30, 2014
SOUTH JORDAN, Utah, July 29, 2014 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, to
Read more →MMSIMerit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the Second Quarter Ended June 30, 2014
SOUTH JORDAN, Utah, July 16, 2014 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, an
Read more →MMSIMerit Medical Receives Regulatory Approval for Tracheobronchial Stent Systems in China
SOUTH JORDAN, Utah, July 9, 2014 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, ann
Read more →MMSIMerit Medical to Present at Wells Fargo Healthcare Conference
SOUTH JORDAN, Utah, June 11, 2014 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate at the Wells Farg
Read more →MMSIMerit Medical Announces Corporate Developments Prior to Shareholder Meeting
SOUTH JORDAN, Utah, June 11, 2014 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced several new product introductions and corporate
Read more →MMSIMerit Medical Reports Sales Up 15% for the Quarter Ended March 31, 2014
Non-GAAP Income from Operations Up 40% Malvern Sales Up 49% China Direct Sales Up 56% SOUTH JORDAN, Utah, April 24, 2014 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardi
Read more →MMSIMerit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the First Quarter Ended March 31, 2014
SOUTH JORDAN, Utah, April 7, 2014 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, an
Read more →MMSIMerit Medical to Present at Sidoti and BTIG Conferences Next Week
SOUTH JORDAN, Utah, March 12, 2014 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate in two investor
Read more →MMSIMerit Medical Announces Sales and Earnings Guidance for 2014
SOUTH JORDAN, Utah, March 3, 2014 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it estimates sales for the full year
Read more →MMSIWest Merit Parkway South Jordan, UT 84095 Telephone: 801-253-1600 Fax: 801-253-1688 PRESS RELEASE FOR IMMEDIATE RELEASE Date
1600 West Merit Parkway South Jordan, UT 84095 Telephone: 801-253-1600 Fax: 801-253-1688 Date: March 3, 2014 Contact: Anne-Marie Wright, Vice President, Corporate Communications Phone: (801) 208-4167 e-mail: awright@merit.com Fax: (801) 253-1688 MERIT MEDICAL ANNOUNCES SALES
Read more →MMSIMerit Medical Systems to Update 2014 Guidance on March 3, 2014
SOUTH JORDAN, Utah, Feb. 28, 2014 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced that it will provide updated guidance regarding
Read more →MMSIMerit Medical to Present at Raymond James Institutional Investors Conference
SOUTH JORDAN, Utah, Feb. 25, 2014 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate at Raymond James
Read more →MMSIMerit Medical Reports Record Revenues for the Quarter and Year Ended December 31, 2013
Revenues Up 17% for the Quarter and 14% for the Year 4Q 2013 Core Growth Up 12% GAAP and Non-GAAP Income Up Over 4Q 2012 SAFEGUARD Product Line Integrated 2014 Guidance Scheduled To Be Given on March 3, 2014 SOUTH JORDAN, Utah, Feb. 24, 2014 (GLOBE NEWSWIRE) -- Merit Medical
Read more →MMSIMerit Medical to Present at RBC Capital Markets' Healthcare Conference
SOUTH JORDAN, Utah, Feb. 18, 2014 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate in RBC Capital Ma
Read more →MMSIMerit Medical Systems to Announce Fourth Quarter and Year End Results on February 24, 2014
SOUTH JORDAN, Utah, Feb. 4, 2014 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that the Company will release its financial
Read more →MMSIMerit Medical to Participate at Noble Financial's Equity Conference
SOUTH JORDAN, Utah, Jan. 9, 2014 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate at Noble Financial
Read more →MMSIMerit Medical to Present at Stephens and Canaccord Genuity Conferences This Week
SOUTH JORDAN, Utah, Nov. 12, 2013 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate in two investor c
Read more →MMSIMerit Medical Announces Results for the Quarter Ended September 30, 2013
Record Sales Up 20% for 3Q Core Business Up 11% for 3Q Improved Performance in All Product Groups and Business Segments Gross Margin Up 150 Basis Points Sequentially 3Q SG&A and R&D Expenses Down 300 Basis Points Sequentially Non-GAAP EPS $0.25 for 3Q SOUTH JORDAN, Utah, Oc
Read more →MMSIMerit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the Third Quarter Ended September 30, 2013
SOUTH JORDAN, Utah, Oct. 7, 2013 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, ann
Read more →MMSIMerit Medical Acquires Assets of Radial Assist
SOUTH JORDAN, Utah, Oct. 7, 2013 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it has acquired the assets of Radial A
Read more →MMSIMerit Medical Acquires Pressure-Assisted Hemostatic Devices From Datascope Corp.
SOUTH JORDAN, Utah, Oct. 7, 2013 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it has acquired from Datascope Corp. t
Read more →MMSIMerit Medical to Participate at Canaccord Genuity Growth Conference
SOUTH JORDAN, Utah, Aug. 1, 2013 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate at the Canaccord G
Read more →MMSIMerit Medical Reports Record Revenues, up Nine Percent, for the Quarter and Six Months Ended June 30, 2013
Gross Margin Improvement of 140 Basis Points Compared to First Quarter 2013 SG&A Expense Down 220 Basis Points Compared to First Quarter 2013 R&D Expense Down 90 Basis Points Compared to First Quarter 2013 Inventory Reduction of $3.0 Million Year to Date SOUTH JORDAN, Utah, J
Read more →MMSIMerit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the Second Quarter Ended June 30, 2013
SOUTH JORDAN, Utah, July 8, 2013 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, ann
Read more →MMSIMerit Medical to Participate at Wells Fargo Healthcare Conference
SOUTH JORDAN, Utah, June 10, 2013 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate at Wells Fargo Se
Read more →MMSIMerit Medical Opens Hypotube Center of Excellence
SOUTH JORDAN, Utah, June 4, 2013 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy today announced the opening of a hypotube manufacturing Cent
Read more →MMSIMerit Medical to Participate at Jefferies Global Healthcare Conference
SOUTH JORDAN, Utah, May 28, 2013 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate at Jefferies 2013
Read more →MMSIMerit Medical Reports Record Sales, Up 9%, for the Quarter Ended March 31, 2013
SOUTH JORDAN, Utah, April 25, 2013 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced record sales of $103.9 million for the qu
Read more →MMSIMerit Medical to Present at Sidoti and Credit Suisse Conferences
SOUTH JORDAN, Utah, March 12, 2013 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate in two upcoming
Read more →MMSIMerit Medical Receives CE Marking for Prostatic Artery Embolization for Embosphere(R) Microspheres
SOUTH JORDAN, Utah, March 7, 2013 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary implantable as well as disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it has receive
Read more →MMSIMerit Medical Reports Record Revenues for the Quarter and Year Ended December 31, 2012 and Gives Sales and Earnings Guidance for 2013
SOUTH JORDAN, Utah, Feb. 21, 2013 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced record revenues of $102.2 million for the
Read more →MMSIMerit Medical to Present at RBC and Lazard Conferences
SOUTH JORDAN, Utah, Feb. 20, 2013 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate in two upcoming i
Read more →MMSIMerit Medical Completes Acquisition of Thomas Medical Products, a Unit of GE Healthcare
SOUTH JORDAN, Utah, Dec. 20, 2012 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. ("Merit") (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it has completed the acquis
Read more →MMSIMerit Medical to Participate at Lazard's Corporate Access Day
SOUTH JORDAN, Utah, Dec. 12, 2012 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate at Lazard Capital
Read more →MMSIMerit Medical Announces 510(k) Clearance for the ONE Snare(TM) System
SOUTH JORDAN, Utah, Dec. 10, 2012 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it has received 510(k) clearance from
Read more →MMSIMerit Medical Acquires Assets of Medigroup
SOUTH JORDAN, Utah, Nov. 29, 2012 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, to
Read more →MMSIMerit Medical Signs Agreement to Acquire Thomas Medical Products, a Unit of GE Healthcare
SOUTH JORDAN, Utah, Nov. 26, 2012 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. ("Merit") (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it has entered into a stock
Read more →MMSIMerit Medical to Present at Lazard and Stephens Conferences
SOUTH JORDAN, Utah, Nov. 8, 2012 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate in two conferences
Read more →MMSIMerit Medical Announces Results for the Quarter Ended September 30, 2012
SOUTH JORDAN, Utah, Oct. 25, 2012 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, to
Read more →MMSIMerit Medical Announces FDA Completes Evaluation
SOUTH JORDAN, Utah, Oct. 23, 2012 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, to
Read more →MMSIMerit Medical Receives 510(k) Clearance to Market the Merit Laureate(R) Hydrophilic Guide Wire
SOUTH JORDAN, Utah, Sept. 24, 2012 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it has received 510(k) clearance fro
Read more →MMSIMerit Medical to Present at CL King, Lazard and UBS Conferences in September
SOUTH JORDAN, Utah, Sept. 6, 2012 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate in three investor
Read more →MMSIMerit Medical Reports Record Revenues, Up Ten Percent, for the Quarter Ended June 30, 2012
SOUTH JORDAN, Utah, July 26, 2012 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, to
Read more →MMSIMerit Medical Reports Record Sales, Up 10%, for the Quarter Ended March 31, 2012
SOUTH JORDAN, Utah, April 24, 2012 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced record sales of $95.6 million for the qua
Read more →MMSIMerit Medical Announces 510(k) Clearance for 30-60um QuadraSphere(R) Microspheres
SOUTH JORDAN, Utah, March 26, 2012 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it has received 510(k) clearance fro
Read more →MMSIMerit Medical to Participate at Sidoti & Company's Emerging Growth Institutional Investor Forum
SOUTH JORDAN, Utah, March 14, 2012 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate at Sidoti & Comp
Read more →MMSIMerit Medical to Participate at Raymond James Institutional Investors Conference
SOUTH JORDAN, Utah, Feb. 27, 2012 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate at Raymond James
Read more →MMSIMerit Medical Reports Record Sales and Net Income for the Year Ended December 31, 2011 and Gives Sales and Earnings Guidance for 2012
Revenues Up 21% for the Year and 12% for the Quarter Gross Margins Up 270 Basis Points for the Year and 150 Basis Points for the Quarter SOUTH JORDAN, Utah, Feb. 23, 2012 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of propr
Read more →MMSIMerit Medical Systems Receives FDA Warning Letter Regarding Merit Laureate(R) Hydrophilic Guidewire
SOUTH JORDAN, Utah, Feb. 7, 2012 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced it received a warning letter from the U.S.
Read more →MMSIMerit Medical Announces the Purchase of the Assets of Ostial Solutions, LLC
SOUTH JORDAN, Utah, Feb. 1, 2012 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it has acquired the assets of Ostial S
Read more →MMSIMerit Medical to Present at Noble Financial Capital Markets' Equity Conference
SOUTH JORDAN, Utah, Jan. 9, 2012 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate at Noble Financial
Read more →MMSIMerit Medical to Present at Piper Jaffray Health Care Conference
SOUTH JORDAN, Utah, Nov. 22, 2011 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate at the 23rd Annua
Read more →MMSIMerit Medical Announces Appointment of Two Directors
SOUTH JORDAN, Utah, Nov. 10, 2011 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it has appointed A. Scott Anderson an
Read more →MMSIMerit Medical Announces Results for the Quarter Ended September 30, 2011
Revenues Up 24% for the Quarter and Year to Date Core Business Up 15% for the Quarter and Year to Date Non-GAAP Net Income Up 25% for the Quarter and Up 28% Year to Date Growth in China Anticipated Due to New Approvals and Tenders New Technology Acquisitions Completed SOUTH
Read more →MMSIMerit Medical Announces Regulatory Approvals for Multiple Products
SOUTH JORDAN, Utah, Sept. 7, 2011 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, to
Read more →MMSIMerit Medical to Present at Stifel Nicolaus Healthcare Conference
SOUTH JORDAN, Utah, Sept. 7, 2011 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, to
Read more →MMSIMerit Medical to Present at CL King, UBS and Jefferies Conferences in September
SOUTH JORDAN, Utah, Sept. 1, 2011 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate in three investor
Read more →MMSIMerit Medical Reports Record Revenues and Earnings for the Second Quarter and Six Months Ended June 30, 2011
Revenues up 22% for the Quarter Core Business up 12% for the Quarter Income From Operations up 24% for the Quarter Gross Margins Up 330 Basis Points for the Quarter Completed $92 Million Equity Offering SOUTH JORDAN, Utah, July 21, 2011 (GLOBE NEWSWIRE) -- Merit Medical Syst
Read more →MMSIMerit Medical Systems, Inc. Announces Closing of Public Offering of Common Stock
SOUTH JORDAN, Utah, June 22, 2011 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it closed its public offering of 5,52
Read more →MMSIMerit Medical Systems, Inc. Prices Common Stock Offering
SOUTH JORDAN, Utah, June 17, 2011 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leader in the development, manufacture and distribution of proprietary disposable medical devices used in interventional and diagnostic procedures, today announced the pricing of it
Read more →MMSIMerit Medical Systems, Inc. Announces Commencement of Public Offering of Common Stock
SOUTH JORDAN, Utah, June 16, 2011 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI) a leader in the development, manufacture and distribution of proprietary disposable medical devices used in interventional and diagnostic procedures, today announced that it intends to
Read more →MMSIMerit Medical to Participate at Jefferies 2011 Global Healthcare Conference
SOUTH JORDAN, Utah, May 26, 2011 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate at the Jefferies 2
Read more →MMSIMerit Medical Announces 5-for-4 Forward Stock Split
SOUTH JORDAN, Utah, April 21, 2011 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that its Board of Directors has approved
Read more →MMSIMerit Medical Reports Record Revenues and Earnings for the Quarter Ended March 31, 2011
Revenues Up 28.5% for the Quarter Core Business Up 17% for the Quarter Income From Operations Up 61% for the Quarter Gross Margins Up 370 Basis Points for the Quarter SOUTH JORDAN, Utah, April 14, 2011 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading m
Read more →MMSIMerit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the First Quarter Ended March 31, 2011
SOUTH JORDAN, Utah, April 12, 2011 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that the Company will release its financi
Read more →MMSIMerit Medical Announces 510(k) Clearance for the ASAP(TM) Thrombus Aspiration Catheter
SOUTH JORDAN, Utah, March 15, 2011 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, t
Read more →MMSIMerit Medical to Participate at Roth Capital Partners Growth Stock Conference
SOUTH JORDAN, Utah, Feb. 28, 2011 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate at Roth Capital P
Read more →MMSIMerit Medical Reports Record Revenues for the Fourth Quarter and Year Ended December 31, 2010 and Gives Sales and Earnings Guidance for 2011
Revenues Up 20% for the Quarter and 15% for the Year Gross Margins Up 430 Basis Point for the Quarter and 100 Basis Points for the Year SOUTH JORDAN, Utah, Feb. 17, 2011 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of propri
Read more →MMSIMerit Medical to Participate at RBC Capital Markets Healthcare Conference
SOUTH JORDAN, Utah, Feb. 16, 2011 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate at RBC Capital Ma
Read more →MMSIMerit Medical Systems to Announce Fourth Quarter and Year End Results on February 17, 2011
SOUTH JORDAN, Utah, Feb. 1, 2011 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that the Company will release its financial
Read more →MMSIMerit Medical to Present at Canaccord Genuity Cardiovascular, Diabetes & Obesity Conference
SOUTH JORDAN, Utah, Nov. 29, 2010 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate at the 5th Annual
Read more →MMSIMerit Medical to Participate at Lazard Capital's Medical Technology Conference
SOUTH JORDAN, Utah, Nov. 24, 2010 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate at Lazard Capital
Read more →MMSIMerit Medical to Present at Sidoti, Stephens and Lazard Conferences Next Week
SOUTH JORDAN, Utah, Nov. 10, 2010 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate in three investor
Read more →MMSIMerit Medical Announces Results for the Quarter Ended September 30, 2010 and Gives Update on Recent Acquisitions
SOUTH JORDAN, Utah, Nov. 4, 2010 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, tod
Read more →MMSIMerit Medical Completes Acquisition of BioSphere Medical
SOUTH JORDAN, Utah, Sept. 13, 2010 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI) today announced the completion of its acquisition of BioSphere Medical, Inc., a leading developer and marketer of embolotherapeutic products for the treatment of uterine fibroids, hyp
Read more →MMSIMerit Medical to Present at CL King's Best Ideas Conference and Stifel Nicolaus' Healthcare Conference
SOUTH JORDAN, Utah, Sept. 8, 2010 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and gastroenterology, today announced that it will participate at CL King
Read more →MMSIMerit Medical to Present at CJS Securities Investor Conference
SOUTH JORDAN, Utah, Aug. 4, 2010 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and gastroenterology, today announced that its Chief Financial Officer Ken
Read more →MMSIMerit Medical Announces Record Sales, Up 16%, for the Second Quarter and Six Months Ended June 30, 2010
SOUTH JORDAN, Utah, July 28, 2010 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and gastroenterol
Read more →MMSIMerit Medical to Present at Noble Financial's Sixth Annual Equity Conference
SOUTH JORDAN, Utah, May 27, 2010 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and gastroenterology, today announced that it will participate at Noble Fi
Read more →MMSIMerit Medical to Present at Jefferies 2010 Global Life Sciences Conference
SOUTH JORDAN, Utah, May 27, 2010 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and gastroenterology, today announced that it will participate at Jefferie
Read more →MMSIMerit Medical Signs Agreement to Acquire BioSphere Medical
SOUTH JORDAN, Utah, May 13, 2010 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI) today announced that it has signed a definitive merger agreement to acquire BioSphere Medical, Inc. (Nasdaq:BSMD) in an all cash transaction valued at approximately $96 million, inclusi
Read more →MMSIMerit Medical Announces 16% Increase in Sales for the Quarter Ended March 31, 2010
SOUTH JORDAN, Utah, April 29, 2010 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and gastroentero
Read more →MMSIMerit Medical to Present at Sidoti & Company's Emerging Growth Institutional Investor Forum
SOUTH JORDAN, Utah, March 16, 2010 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and gastroenterology, today announced that it will participate at Sidoti
Read more →MMSIMerit Medical to Present at Roth Capital Partners' Growth Stock Conference
SOUTH JORDAN, Utah, March 5, 2010 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and gastroenterology, today announced that it will participate in Roth Ca
Read more →MMSIMerit Medical to Present at Raymond James' Institutional Investors Conference
SOUTH JORDAN, Utah, March 4, 2010 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and gastroenterology, today announced that it will participate in Raymond
Read more →MMSIMerit Medical to Participate in Lazard Capital Markets Conference
SOUTH JORDAN, Utah, Feb. 19, 2010 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and gastroenterology, today announced that it will participate in Lazard
Read more →MMSIMerit Medical Reports Record Sales and Earnings for the Year Ended December 31, 2009
SOUTH JORDAN, Utah, Feb. 18, 2010 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and gastroenterology, today announced record revenues of $257.5 million f
Read more →MMSIMerit Medical's Chief Executive Invited to the President's Forum on Jobs and Economic Growth
SOUTH JORDAN, Utah, Nov. 30, 2009 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and gastroenterol
Read more →MMSIMerit Medical to Participate at Piper Jaffray's Health Care Conference
SOUTH JORDAN, Utah, Nov. 24, 2009 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and gastroenterol
Read more →MMSIMerit Medical Announces 510(K) Clearance for the Merit Laureate(TM) Hydrophilic Guide Wire
SOUTH JORDAN, Utah, Nov. 10, 2009 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and gastroenterol
Read more →MMSIMerit Medical to Present at Sidoti's Emerging Growth Conference
SOUTH JORDAN, Utah, Nov. 9, 2009 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and gastroenterolo
Read more →MMSIMerit Medical to Present at Canaccord Adams' Cardiovascular Conference
SOUTH JORDAN, Utah, Nov. 2, 2009 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and gastroenterolo
Read more →MMSIMerit Medical Announces Record Sales, Up 15%, and Record Earnings, Up 17%, for the Third Quarter Ended September 30, 2009
SOUTH JORDAN, UTAH, Oct. 27, 2009 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and gastroenterol
Read more →MMSIMerit Medical Systems Announces Three-Part Deal With Vysera Biomedical Limited
SOUTH JORDAN, Utah, Oct. 27, 2009 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and gastroenterology procedures, announced today that the Company has com
Read more →MMSIMerit Medical to Present At CL King's Best Ideas Conference
SOUTH JORDAN, Utah, Sept. 9, 2009 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and gastroenterol
Read more →MMSIMerit Medical to Present At Thomas Weisel's Healthcare Conference
SOUTH JORDAN, Utah, Sept. 2, 2009 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and gastroenterol
Read more →MMSIMerit Medical to Present At Canaccord Adams' Global Growth Conference
SOUTH JORDAN, Utah, Aug. 4, 2009 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and gastroenterolo
Read more →MMSIMerit Medical Announces Record Sales, Up 13 Percent, for the Second Quarter Ended June 30, 2009
SOUTH JORDAN, Utah, July 28, 2009 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and gastroenterol
Read more →MMSIMerit Medical to Present At Jefferies Healthcare Conference
SOUTH JORDAN, Utah, June 11, 2009 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and gastroenterology procedures, today announced that it will participate
Read more →MMSIMerit Medical Acquires EN Snare(r) Product Rights From Hatch Medical
SOUTH JORDAN, Utah, June 3, 2009 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and gastroenterolo
Read more →MMSIMerit Medical to Present At Bank of America's Health Care Conference
SOUTH JORDAN, Utah, May 5, 2009 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and gastroenterolog
Read more →MMSIMerit Medical Announces 28 Percent Increase in Net Income On Record Sales and Improved Gross Margins for the First Quarter Ended March 31, 2009
SOUTH JORDAN, Utah, April 28, 2009 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and gastroentero
Read more →MMSIMerit Medical Announces 510(k) Clearance
SOUTH JORDAN, Utah, April 15, 2009 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and gastroenterology procedures, announced today that it has received 51
Read more →MMSIMerit Medical to Present At Lazard Capital Markets' Medical Technology Conference
SOUTH JORDAN, Utah, March 17, 2009 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and gastroenterology procedures, today announced that it will participat
Read more →MMSIMerit Medical to Present At Sidoti's Emerging Growth Conference
SOUTH JORDAN, Utah, March 16, 2009 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and gastroenterology procedures, today announced that it will participat
Read more →MMSIMerit Medical Announces Closing of Alveolus and Biosearch Deals
SOUTH JORDAN, Utah, March 16, 2009 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and gastroenterology procedures, today announced that the previously sig
Read more →MMSIMerit Medical to Present At Raymond James' Investors Conference
SOUTH JORDAN, Utah, March 3, 2009 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, today announced that it will participate at Raymond James'
Read more →MMSIMerit Medical Announces 2009 Sales and Earnings Guidance Including Anticipated Effects of Alveolus and Biosearch Transactions
SOUTH JORDAN, Utah, Feb. 19, 2009 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, today announced sales and earnings guidance regarding management's
Read more →MMSIMerit Medical Announces Agreement to Acquire Assets of Alveolus, Inc.
SOUTH JORDAN, Utah, Feb. 19, 2009 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, announced today that it has signed a definitive agreement to acqui
Read more →MMSIMerit Medical Systems to Give Sales and Earnings Guidance For 2009
SOUTH JORDAN, Utah, Feb. 19, 2009 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, announced today that the Company will give sales and earni
Read more →MMSIMerit Medical Reports Record Sales and Earnings for the Year Ended December 31, 2008
SOUTH JORDAN, Utah, Feb. 5, 2009 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, today announced record revenues of $227.1 million for the year ende
Read more →MMSIMerit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the Fourth Quarter and Year Ended December 31, 2008
SOUTH JORDAN, Utah, Feb. 2, 2009 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, announced today that the Company will release its financial
Read more →MMSIMerit Medical Announces Microcatheter Market Entry
SOUTH JORDAN, Utah, Jan. 14, 2009 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, announced today that it will enter the microcatheter marke
Read more →MMSIMerit Medical Announces Year-End Developments
SOUTH JORDAN, Utah, Dec. 30, 2008 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, today announced four developments regarding products and a
Read more →MMSIMerit Medical to Present At Piper Jaffray Health Care Conference
SOUTH JORDAN, Utah, Nov. 20, 2008 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, today announced that it will participate at the 20th Annua
Read more →MMSIMerit Medical to Present At Stephens Fall Investment Conference
SOUTH JORDAN, Utah, Nov. 12, 2008 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, today announced that it will participate at Stephens Fall
Read more →MMSIMerit Medical Reports Record Revenues Up 15 Percent and Improved Earnings for the Third Quarter of 2008
SOUTH JORDAN, Utah, Oct. 23, 2008 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, today reported record revenues of $58.2 million for its th
Read more →MMSIMerit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the Third Quarter Ended September 30, 2008
SOUTH JORDAN, Utah, Oct. 15, 2008 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, announced today that the Company will release its financia
Read more →MMSIMerit Medical to Present at the UBS Global Life Sciences Conference
SOUTH JORDAN, Utah, Sept. 15, 2008 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, today announced that it will present at the UBS Global Li
Read more →MMSIMerit Medical Discusses Angleton, Texas Facility
SOUTH JORDAN, Utah, Sept. 15, 2008 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, today announced that its facility located in Angleton, Te
Read more →MMSIMerit Medical to Present At the Credit Suisse Under Followed Opportunities Conference
SOUTH JORDAN, Utah, Sept. 3, 2008 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, today announced that it will participate in the Credit Sui
Read more →MMSIMerit Medical Announces Lineup of New Product Introductions
SOUTH JORDAN, Utah, Sept. 2, 2008 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, today announced five new products that are scheduled to be
Read more →MMSIMerit Medical to Present At Thomas Weisel Partners Healthcare Conference
SOUTH JORDAN, Utah, Aug. 21, 2008 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, today announced that it will present at the Thomas Weisel
Read more →MMSIMerit Medical to Present At the Noble Financial Equity Conference
SOUTH JORDAN, Utah, Aug. 6, 2008 (PRIME NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, today announced that it will participate in the Fourth Annu
Read more →MMSIMerit Medical Announces Updated Guidance for Gross Margins, Profits and Sales
SOUTH JORDAN, Utah, July 23, 2008 (PRIME NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, today announced that the Company has updated its guidance
Read more →MMSIMerit Medical Reports 62 Percent Increase in Net Earnings On 500-Basis Point Gross Margin Improvement
SOUTH JORDAN, Utah, July 23, 2008 (PRIME NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, today announced record revenues of $57.4 million for its s
Read more →MMSIMerit Medical to Present At CapStone Investments Conference
SOUTH JORDAN, Utah, June 12, 2008 (PRIME NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, announced today that it will present at CapStone Investmen
Read more →MMSIMerit Medical to Present At the FBR Capital Markets Spring Investor Conference
SOUTH JORDAN, Utah, May 14, 2008 (PRIME NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, announced today that it will present at the FBR Capital Mar
Read more →MMSIMerit Medical Announces 50 Percent Increase in EPS on Improved Sales and Gross Margins
SOUTH JORDAN, Utah, April 24, 2008 (PRIME NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, today announced sales of $53.6 million for the first quar
Read more →MMSIMerit Medical to Present At the Raymond James Investors Conference
SOUTH JORDAN, Utah, Feb. 26, 2008 (PRIME NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, announced today that it will present at the Raymond James
Read more →MMSIMerit Medical Reports Record 4Q Revenues and Net Income Up 55 Percent
SOUTH JORDAN, Utah, Feb. 14, 2008 (PRIME NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, today announced financial results for the fourth quarter and fisca
Read more →MMSIMerit Medical Finalizes Two Deals
SOUTH JORDAN, Utah, Feb. 13, 2008 (PRIME NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, announced today that the Company has finalized two transactions.
Read more →MMSIMerit Medical to Present At Roth Capital's OC Growth Stock Conference
SOUTH JORDAN, Utah, Feb. 11, 2008 (PRIME NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, is scheduled to present at Roth Capital Partners' 20th Annual OC C
Read more →MMSIMerit Medical to Report Results Ahead of Previously Announced Forecasts
SOUTH JORDAN, Utah, Jan. 15, 2008 (PRIME NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, announced today that it expects to report results for the
Read more →MMSIMerit Medical Announces 510(k) Notification For New Sea Dragon Torque Device
SOUTH JORDAN, Utah, Dec. 20, 2007 (PRIME NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, announced today that it has received notification from the
Read more →MMSIMerit Medical to Host Investor Meetings in San Francisco
SOUTH JORDAN, Utah, Dec. 19, 2007 (PRIME NEWSWIRE) -- Merit Medical Systems Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, announced today that its Chairman and CEO Fred P. Lampropou
Read more →MMSIMerit Medical Announces 510(k) Notification for Two Additional Products
SOUTH JORDAN, Utah, Nov. 28, 2007 (PRIME NEWSWIRE) -- Merit Medical Systems Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, announced today that it has received notification from the
Read more →MMSIMerit Medical Announces 510(k) Notification for Resolve Biliary Catheter
SOUTH JORDAN, Utah, Nov. 26, 2007 (PRIME NEWSWIRE) -- Merit Medical Systems Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, announced today that it has received notification from the
Read more →MMSIMerit Medical to Present At the Stephens Fall Investment Conference
SOUTH JORDAN, Utah, Nov. 6, 2007 (PRIME NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, announced today that it will present at the Stephens Fall I
Read more →MMSIMerit Medical to Acquire Cardiac and Peripheral Assets From Micrus Endovascular
SOUTH JORDAN, Utah, Nov. 5, 2007 (PRIME NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, announced today that it entered into a non-binding term she
Read more →MMSIMerit Medical Systems Announces Improved Gross Margins and Profits for 3Q 2007
SOUTH JORDAN, Utah, Oct. 25, 2007 (PRIME NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, today reported revenues of $50.6 million for its third qua
Read more →MMSIMerit Medical to Present At the CIBC World Markets Healthcare Conference
SOUTH JORDAN, Utah, Oct. 24, 2007 (PRIME NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, announced today that it will present at the CIBC World Mar
Read more →MMSIMerit Medical Announces Improvement in Gross Margins and Profits and Conference Call Information for 3Q 2007
SOUTH JORDAN, Utah, Oct. 15, 2007 (PRIME NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, announced today that gross margins for the third quarter e
Read more →MMSIMerit Medical to Present At the UBS Global Life Sciences Conference
SOUTH JORDAN, Utah, Sept. 19, 2007 (PRIME NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, is scheduled to participate in the UBS Global Life Scienc
Read more →MMSIMerit Medical Announces Exclusive Distribution Deal for Microcatheter
SOUTH JORDAN, Utah, Aug. 15, 2007 (PRIME NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, announced today that it has acquired the exclusive distrib
Read more →MMSIMerit Medical to Present At the Noble Financial Two Double-O-Seven Conference
SOUTH JORDAN, Utah, Aug. 13, 2007 (PRIME NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, announced today that it will present at the Noble Financia
Read more →MMSIMerit Medical Announces 2Q 2007 Results
SOUTH JORDAN, Utah, July 26, 2007 (PRIME NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, today announced record revenues of $51.8 million for its s
Read more →MMSIMerit Medical Announces 510(k) Notification for Transradial Catheterization
SOUTH JORDAN, Utah, July 24, 2007 (PRIME NEWSWIRE) -- Merit Medical Systems Inc. (Nasdaq: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, announced today that it has received notification from the
Read more →MMSIMerit Medical Acquires Radiopaque Laminate Technology
SOUTH JORDAN, Utah, July 24, 2007 (PRIME NEWSWIRE) -- Merit Medical Systems Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, announced today that it has acquired technology from Lighte
Read more →MMSIMerit Medical Launches ProGuide Chronic Dialysis Kit
SOUTH JORDAN, Utah, May 24, 2007 (PRIME NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable products used primarily in cardiology and radiology procedures, announced today that the ProGuide(tm) chronic dialysis cat
Read more →MMSIMerit Medical to Present at Bank of America Health Care Conference
SOUTH JORDAN, Utah, May 22, 2007 (PRIME NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable accessories used primarily in cardiology and radiology procedures, will participate in Bank of America's 2007 Health Care
Read more →MMSIMerit Medical to Participate in Brean Murray's Healthcare Conference
SOUTH JORDAN, Utah, May 8, 2007 (PRIME NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, is scheduled to participate in Brean Murray, Carret & Co.'s
Read more →MMSIMerit Medical Announces Stock Repurchase Plan
SOUTH JORDAN, Utah, May 2, 2007 (PRIME NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, announced today that its Board of Directors has authorized t
Read more →MMSIMerit Medical Announces Increased Sales and Improved Earnings
SOUTH JORDAN, Utah, May 2, 2007 (PRIME NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, today announced revenues of $51.0 million for the first quar
Read more →MMSIMerit Medical Announces Earnings Release Date/Time and Conference Call Information For First Quarter 2007
SOUTH JORDAN, Utah, April 24, 2007 (PRIME NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a manufacturer and marketer of proprietary disposable accessories used in cardiology and radiology procedures, announced today that the Company will release its financial results for
Read more →MMSIMerit Medical Repurchases 344,084 Shares in Private Transaction
SOUTH JORDAN, Utah, April 3, 2007 (PRIME NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, announced today that it has repurchased in a private trans
Read more →MMSIMerit Medical to Present At SunTrust Robinson Humphrey's Institutional Conference
SOUTH JORDAN, Utah, April 2, 2007 (PRIME NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, will participate in SunTrust Robinson Humphrey's 36th Annu
Read more →MMSIMerit Medical Gives 2007 Sales and Earnings Guidance
SOUTH JORDAN, Utah, March 29, 2007 (PRIME NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, today provided sales and earnings guidance regarding mana
Read more →MMSIMerit Medical Reports 19 Percent Increase in Revenue for the Fourth Quarter Ended December 31, 2006
SOUTH JORDAN, Utah, Feb. 28, 2007 (PRIME NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, today announced financial results for the fourth quarter and fisca
Read more →MMSIMerit Medical Acquires Proguide Chronic Dialysis Catheter From Datascope
SOUTH JORDAN, Utah, Feb. 27, 2007 (PRIME NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, announced today that it has acquired the ProGuide chronic dialysis
Read more →MMSIMerit Medical Acquires Exclusive Rights to Abdominal Retraction System
SOUTH JORDAN, Utah, Feb. 21, 2007 (PRIME NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, announced today that it has entered into an exclusive distribution
Read more →MMSIMerit Medical to Present at Roth Capital's OC Conference
SOUTH JORDAN, Utah, Feb. 14, 2007 (PRIME NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, is scheduled to present at Roth Capital Partners' 19th Annual OC C
Read more →MMSIMerit Medical Introduces New Safety Product
SOUTH JORDAN, Utah, Feb. 5, 2007 (PRIME NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, announced today the introduction of a new, patented safety
Read more →Competitive Position
How MMSI ranks across every disease it competes inCompetitive Position is a premium feature
See how MMSI ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial